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A Abstract 
 
In this work passive and iontophoretic transport of a dipeptide, Tyrosine-Phenylalanine 
(TyrPhe), a protected amino acid, Tyrosine-β-Naphthylamide (Tyrβ-NA), and a glucose 
derivative, Benzyl-2-Acetamido-2-deoxy-α-D-glucopyranoside (BAd-α-Glc), was investigated 
across heat-separated human epidermis in vitro. The modified Nernst-Planck Equation was 
used to theoretically describe permeation of these compounds. Permeation experiments 
were carried out with custom-made glass diffusion cells connected to a four-electrode system 
developed in our laboratories to generate constant voltage. Ag/AgCl electrodes with the 
anode in the donor compartment were used to apply the potential difference across the skin 
and reference Ag/AgCl electrodes, reaching either side of the membrane with Luggin 
capillaries, were used to precisely control and maintain constant the potential drop across the 
membrane. Permeation was studied at pH 3 and 4.5, for which the TyrPhe and Tyrβ-NA are 
positively charged. 
The contribution of charge, lipophilicity, skin retention, electroosmosis and the influence of 
skin metabolism on the permeation rate of the above mentioned substances was examined. 
 
 pKa of TyrPhe and Tyrβ-NA was determined by potentiometric titration to be 3.50 and 4.78, 
respectively. The average net ionic valence of TyrPhe was 0.76 and 0.091 at pH 3 and 4.5, 
respectively and that of Tyrβ-NA was 0.98 and 0.66 at pH 3 and 4.5, respectively. 
n-octanol/aqueous buffer partition coefficients were determined using shaking flask method 
to be for BAd-α-Glc 0.13 and 0.11 at pH 3 and 4.5,respectively and for TyrPhe 0.80 and 0.61 
at pH 3 and 4.5, respectively and for Tyrβ-NA 4.81 and 7.28 at pH 3 and 4.5, respectively. 
Enzymatic stability of TyrPhe was determined by reflection boundary set-up. A degradation 
of 12% at pH 3 and 45% at pH 4.5 was measured over 69 hours at 37°C. For BAd-α-Glc the 
generation of less than 0.5% of benzyl alcohol, the product of glycosidase action, was found. 
Tyrβ-NA was stable because of the side-chain protecting group. 
 
A typical permeation experiment involved three experimental stages. After a first passive 
stage over 44 hours, 250 mV were applied for 3 hours followed by a second passive stage of 
22 hours.  
Membrane resistance during the three hours of iontophoresis remained constant or showed 
only small decline. These results guaranteed the integrity of the membrane under the present 
experimental conditions.  
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The influence of TyrPhe skin metabolism on its own permeation rate and skin retention as 
well as on the permeation rate and skin retention of BAd-α-Glc was examined. No 
reproducible permeation of TyrPhe at pH 3 and no permeation at all at pH 4.5 was measured 
when the dipeptide was used alone or in combination with BAd-α-Glc. Additionally, higher 
fluxes of the degradation products Tyrosine (Tyr) and Phenylalanine (Phe) were observed 
and higher levels of Tyr and Phe were recovered from the epidermis compared to blank runs. 
Blank runs reflected endogenous levels of Tyr and Phe. Degradation was inhibited by the 
use of o-phenanthroline at pH 3 but not at pH 4.5 and at both pH values at low temperature 
(4°C). Inhibition was verified by reproducible TyrPhe permeation and blank level Tyr and Phe 
fluxes and tissue recovery. These results confirm degradation of TyrPhe by cutaneous 
metabolism in heat-separated human epidermis, that was stronger at pH 4.5 compared to 
pH 3. BAd-α-Glc showed at both pHs smaller iontophoretic fluxes compared to the passive 
ones, indicating an electroosmotic flux from cathode to anode. In combination with TyrPhe, 
iontophoretic fluxes of BAd-α-Glc increased significantly when TyrPhe was metabolized in 
the tissue, while no such decrease was observed when TyrPhe metabolism was inhibited. 
This increase of BAd-α-Glc iontophoretic flux was accompanied by a considerable decrease 
of BAd-α-Glc amount retained in the epidermis. The generated Tyr and Phe appear, 
therefore, to decrease BAd-α-Glc amount retained in the epidermis and enhance 
iontophoretic flow. Thus, an interaction between the concurrent permeants at the level of 
tissue retention induced by metabolism can influence iontophoretic permeation of these 
poorly permeable compounds. So far only Tyr and Phe were able to show this effect. On the 
other hand, Tyr and Phe did not affect iontophoretic permeation of TyrPhe and Tyrβ-NA. This 
demonstrates that the effect of Tyr and Phe is not universal but depends on the permeant.  
The effect of lipophilicity and electroosmosis was assessed simultaneously for all three 
permeants, which spanned a 70-fold range of lipophilicity, in the absence of extraneous Tyr 
and Phe using a theoretical model for the enhancement factor. This was based on the 
modified Nernst-Planck Equation, extended by the ratio of permeability coefficients for lipid 
and aqueous pathway and including an estimate of the ionic valence of permeants in the 
aqueous domain of the tissue. At pH 4.5 a very weak electroosmotic flow from cathode to 
anode was observed, indicating an isoelectric point of the skin slightly above 4.5. At pH 3 
electroosmotic flow was approximately 10-fold stronger than at pH 4.5. The ratio of the 
permeability coefficients for lipid and aqueous pathways resulted for all compounds at both 
pHs in values much smaller than 1, indicating that the aqueous pathway dominated 
transepidermal permeation. The simultaneous analysis of the results of all substances shows 
that the applied model evaluation affords a quantitative assessment of the effect of ionic 
valence, lipophilicity and electroosmosis and makes possible to predict the outcome of 
iontophoresis. 
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B Introduction and Objectives 
 
Ongoing progress in biotechnology and continuing efforts in peptide and protein chemistry 
provide a steady source of new peptide drug candidates. These drugs are currently delivered 
mostly by injection because of the proteolytic enzymes in the gastro-intestinal tract and the 
extensive first-pass hepatic metabolism. Alternatives to the classical parenteral application 
are desirable, because the peptides with their short half-life need to be injected frequently. 
Transdermal permeation of peptides into and through the skin proceeds only to a small 
extent due to their hydrophilicity and large molecule size and due to the lipophilic nature of 
the stratum corneum. To overcome the problem of poor transport, the use of physical 
methods, like iontophoresis, has been examined. 
Iontophoresis is a method to enhance and regulate transdermal drug permeation and 
delivery by application of an electric field on the skin. Next to the direct effect of the electrical 
field driving ionic permeants into the skin, secondary phenomena such as electroosmosis 
and membrane alterations contribute to iontophoretic flux of charged and uncharged 
permeants. Since almost 30 years the interest in systemic delivery by transdermal 
iontophoresis has increased strongly. Numerous groups investigated the mechanisms of 
iontophoretic enhancement, especially electroosmosis (Burnette and Ongpipattanakul 1987, 
Burnette and Ongpipattanakul 1988, Sims et al. 1991, Delgado-Charro and Guy 1994). One 
point of interest was the determination of the isoelectric point of the skin  (Hoogestraate et al. 
1994, Luzardo-Alverez et al. 1998, Marro et al. 2001) and consequently the behavior of the 
electroosmotic flow at different net charges of the skin. Mainly the permeation behavior of 
drugs at physiological pH, where the skin carries a net negative charge indicating an 
electroosmotic flow in the same direction as current flow, has been examined (Hirvonen et al. 
1996, Peck et al. 1996, Kirjavainen et al. 2000). 
Important factors for transdermal permeation are the skin structure and the nature of the 
permeant. In the simplest theory, the stratum corneum consists of an aqueous and lipid 
pathway, whereas the aqueous pathway essentially contributes to iontophoretic transport.  
Generally hydrophilic compounds prefer to permeate through aqueous pathways and result 
in higher iontophoretic enhancement than lipophilic permeants (Del Terzo et al. 1989, 
Hirvonen et al. 1998). Partitioning of a permeant between aqueous and lipid pathway, and 
consequently iontophoretic permeation, are pH-dependent (Lütolf 1997).  
Skin structure and physico-chemical characteristics of the permeant are not only relevant for 
skin permeation but also for skin accumulation. Permeants crossing the skin may adsorb at 
skin components such as proteins. These interactions can result from physical attraction like 
week non-covalent bonding up to strong covalent bonding (Barry 1983). The accumulation of 
permeants in the skin is known from various drugs like steroids, methotrexate (Alvarez-
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Figueroa et al. 2001), fentanyl (Thysman et al. 1995) and insulin (Banga and Chien 1993b). 
A higher amount of fentanyl was brought into the skin by iontophoretic application, which was 
slowly released after cutting off the current. 
Transdermal application was considered for a long time as the most important alternative to 
parenteral application, because cutaneous metabolism was underestimated and/or ignored. 
Many different kinds of enzymes, such as dipeptidase, carboxypeptidase and 
aminopeptidase, were found in the skin, which potentially catalyze the metabolism of, for 
example, peptides (Steinsträsser and Merkle 1995). Today opinions still differ about where 
and to what extent cutaneous metabolism occurs. It is assumed that both the epidermis, 
because of the cell differentiation existing in this layer, as well as the dermis, with hair 
follicles and sebaceous glands, play an important role in metabolic degradation (Bucks 1984, 
Steinsträsser and Merkle 1995). Metabolism may be used for the application of so-called 
prodrugs, substances with good physico-chemical characteristics for transdermal 
permeation, which are converted to the active drug by cutaneous metabolism (Loftsson et al. 
1981, Sloan and Bordor 1982). 
 
The aim of this thesis was to establish a quantitative understanding of the influence of 
charge, lipophilicity, cutaneous metabolism and tissue retention of permeants on 
iontophoretic transport. The dipeptide Tyrosine-Phenylalanine and the protected amino acid 
Tyrosine (Tyrosine-β-Naphthylamide) were used as model permeants, Benzyl-2-Acetamido-
2-deoxy-α-D-glucopyranoside, a glucose derivative, as electroosmotic flow marker. These 
compounds varied widely in their lipophilicity and could have been susceptible to enzymatic 
degradation. Formulation pH was used as a means to control ionic valence of the 
compounds and electroosmotic flow. pH values were chosen in the area of the isoelectric 
point of the skin that determines skin charge and therefore the direction of electroosmotic 
flow. Enzymatic degradation and its effect on iontophoresis were validated with inhibition 
experiments. Iontophoretic transport was investigated in part simultaneously for the above 
permeants in order to detect possible interactions between them and/or their metabolic 
products. These experiments, supported by a theoretical model analysis, were designed for 
the purpose of providing a framework for predicting iontophoretic delivery. Studies were 
carried out in vitro across heat-separated human epidermis using horizontal glass cells 
connected to a four-electrode system (constant voltage). Fluxes of the permeants and their 
degradation products across the epidermis and their accumulation in the epidermis were 
measured. Changes of the electrical characteristics of the skin during experiments were 
constantly monitored. 
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C Theoretical Introduction 
C.1 Skin 
C.1.1 Anatomy of the skin 
 
The skin is the largest and most accessible organ of the body with a surface area of 
1.5-1.8 m2 (Junqueira and Carneiro 1996). This great amount of exposed area acts as a 
permeability barrier to the environment reduces water loss and provides protection against 
abrasive action and microorganisms (Schaefer and Redelmeier 1996a). It contains a varied 
complement of different cells, but it is generally described in terms of three tissue layers: the 
epidermis, the dermis and the hypodermis. Figure 1 shows the viable epidermis with the 
outmost layer, the stratum corneum and the dermis (Banga and Chien 1993a). 
 
 
Stratum corneum 
Viable Epidermis 
Dermis 
 
Figure 1. The composition of human skin 
 
C.1.1.1 Epidermis 
 
The epidermis is a continually renewing, stratified, squamous epithelium that keratinizes and 
is penetrated by appendages like hair, nails, sweat and sebaceous glands. 
The majority of cells are keratinocytes, which contain keratin filaments in the cytoplasma and 
form desmosomes with adjacent cells. The keratinocytes are organized into several layers, 
which represent different stages of differentiation (Holbrook and Wolff 1993), see Figure 2. 
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Figure 2. Different layers of the epidermis 
 
 
The outmost layer, the stratum corneum, is about 20 µm thick. It consists of corneocytes or 
horny cells, which are remnants of the terminus differentiation of the viable epidermis. During 
the process of cornification the cellular organelles and cytoplasma disappear so that the 
corneocytes are built of insoluble bundled keratins surrounded by a cell envelope stabilized 
by cross-linked proteins and covalently bound lipids. The physical properties are supported 
and maintained by low-molecular-weight components such as amino acids, sugars, salts and 
water. A great variety of the low-molecular-weight compounds may derive from metabolism 
as well as other sources including sweat (Schaefer and Redelmeier 1996b). 
The intercellular region is generated from exocytosis of lamellar bodies (Wertz et al. 1989). 
This intercellular domain is the only continuous domain and forms the skin barrier (Schaefer 
and Redelmeier 1996a). The principal lipids are ceramides, saturated free fatty acids and 
cholesterol. 
The stratum corneum can be subdivided in two layers, the stratum compactum and the 
stratum disjunctum. The interface between the terminally differentiated keratinocytes 
(stratum lucidum) and the lower layer the stratum compactum is a zone of transition and 
rapid transformation and is very important for metabolic activity. In the stratum disjunctum, 
reductions in the number of corneodesmosomes reflect changes in the composition of the 
stratum corneum during the latter stages of desquamation (Schaefer and Redelmeier 
1996a). 
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The horny cells are formed and continuously replenished by the slow upward migration of 
cells, produced by the stratum basale, which is the regenerative layer of the epidermis. The 
transition from the living cells to the dead, cornified cells of the stratum corneum is made 
prominent by tow layers, the stratum spinosum and stratum granulosum. In the process of 
degradation, which occurs in this transition zone, granules of keratohyaline appear in the 
cells. When theses granules have completely changed into keratin, the cells assume a 
homogeneous appearance to form the stratum lucidum (Chien 1992).  
 
The epidermis also contains melanocytes involved in skin pigmentation, Langerhans cells 
which are important for antigen presentation and immune responses and Merkel cells which 
play a role in sensory reception (Schaefer and Redelmeier 1996a). 
 
C.1.1.2 Dermis 
 
The stratum basale is connecting the epidermis with the dermis. The dermis is an integrated 
system of fibrous, filamentous and amorphous connective tissue that accommodates nerve 
and vascular networks (Holbrook and Wolff 1993). This system determines the tensile 
strength and elasticity of the skin (Schaefer and Redelmeier 1996a), protects the body from 
mechanical injury, binds water, functions as a water storage organ and as a receptor of 
sensory stimuli, participates in thermal regulation and in immunological protection. Cellular 
residents include fibroblasts, endothelial cells and mast cells. A variety of appendages, which 
permeate the epidermis, are derived from this tissue. 
 
The dermis is generally described in terms of two tissue layers: stratum papillare and stratum 
reticulare. The two layers only differ in the density and organization of their fibrous 
connective tissue. Both layers are rich in proteoglycans and glycosaminoglycans (Junqueira 
and Carneiro 1996). 
 
C.1.1.3 Hypodermis 
 
The hypodermis contains loose connective tissue and adipocytes, which are responsible for 
the energy storage and metabolism as well as for the cushion and protection of the skin 
(Holbrook and Wolff 1993). The intercellular fat droplets may act as reservoirs for 
hydrophobic compounds. However, the hypodermis contains also an extensive circulatory 
network, so that most permeating compounds can be considered to be distributed throughout 
the body (Schaefer and Redelmeier 1996a). 
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C.1.1.4 Appendages 
 
Various appendages penetrate the stratum corneum and epidermis providing different 
functions. Although they account for no more than 0.1% of the total skin surface area, they 
cannot be neglected in considering possible routes of percutaneous absorption. 
 
C.1.1.4.1 Sweat glands 
 
Sweat glands are distributed almost over the whole body at a density of approximately 400 
glands /cm2. They decrease the skin temperature by secreting a nearly isotonic solution. 
 
C.1.1.4.2 Hair follicles 
 
Hair follicles extend between less than 1 mm into the dermis and more than 3 mm into the 
hypodermis. The average density is about 40-50/cm2, which is less than the density for sweat 
glands, but their average surface area may be larger (Chien 1992). 
Associated with the hair follicle is a sebaceous gland. The ducts of sebaceous glands join the 
hair follicles approximately 0.5 mm below the surface of the skin (Schaefer and Redelmeier 
1996a). 
In the initial diffusion state hair follicles are one of the most important sites for percutaneous 
penetration (Chien 1992). The inner root sheath surrounding the hair shaft presents an 
opportunity for molecules to diffuse along the hair follicle. This compartment is filled with 
sebum, which does not form a barrier to diffusion (Schaefer and Redelmeier 1996a). When a 
steady diffusion state has been reached, diffusion through the stratum corneum becomes the 
dominant pathway (Chien 1992). 
 
C.1.1.4.3 Sebaceous glands 
 
Sebaceous glands are found except on the palms of the hands and sole of the feet in all 
regions of the body. They are connected with a duct to the hair follicle where they deliver the 
sebum. During this secretion the entire sebaceous cell breaks down (Junqueira and Carneiro 
1996). The sebum is composed primarily of triglycerides and free fatty acids with fewer 
amounts of squalene and waxes. 
It is generally accepted that sebum does not participate in the barrier function of the skin. It 
has to be considered that there may be a possibility of influence to percutaneous absorption 
by a mix of sebum with topically applied formulations (Schaefer and Redelmeier 1996a). 
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C.1.2 The main barrier of the skin 
 
The primary barrier to percutaneous absorption is located within the superficial layer, the 
stratum corneum. The formation of the stratum corneum is under homeostatic control. That 
means the processes of cornification and desquamation are intimately linked. 
The structure of corneocytes and intercellular lipid forms the physical basis for the barrier 
function (‘brick and mortar’-model). 
The most satisfying proof of stratum corneum being the main barrier to permeation is 
provided by the simple demonstration that physically stripping of the outermost layers of the 
skin results in a dramatic increase in permeability to water (Scheuplein and Blank 1971) and 
other compounds (Schaefer et al. 1982). A sequential increase in transepidermal water loss 
is observed as the stratum corneum is progressively removed, indicating that the whole of 
the stratum corneum provides the barrier of diffusion (Bommannan et al. 1990). An entire 
removal of this layer results in a significant, but not complete reduction in barrier properties 
(Schaefer and Redelmeier 1996b). 
The stratum corneum contains approximately 15% water, 70% protein and 15% lipid. In 
comparison, the composition of a keratinocyte in the viable epidermis is approximately 70% 
water, 15% protein, 5% nucleic acid and 5% lipid. 
 
C.1.3 Penetration pathways across the stratum corneum 
 
The stratum corneum contains protein-rich regions corresponding to the corneocytes and 
lipid-rich regions, which correspond to the intercellular lipid (‘brick and mortar’-model). 
This morphological organization of the stratum corneum determines possible penetration 
pathways (Schaefer and Redelmeier 1996b). 
 
There are three possible routes to percutaneous absorption: transcellular, intercellular and 
appendagael. These pathways are not mutually exclusive and the importance of each route 
depends on their frequency (area) and path length as well as the diffusivity and solubility of 
the compound in each domain (Schaefer and Redelmeier 1996b). 
(a) Transcellular diffusion, in which the drug diffuses through the cornified cells is one 
possibility. The whole thickness of the stratum corneum contributes to the diffusional 
resistance. The main arguments against this route are that the cornified cells themselves 
are dense and offer a large diffusional resistance (Hadgraft 1983). 
(b) Intercellular lipid domain is the only continuous region within the stratum corneum. 
Although it has a small surface area, the diffusional resistance is fairly low compared to 
the dead cells (Hadgraft 1983). 
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The intercellular lipid can be modeled as flattened multilamellar vesicles. Therefore the 
diffusion of compounds occurs along lipid lamellae. An alternative model is that the 
lamellae form a continuous barrier, which surround the corneocytes. In this case the 
compounds transverse the lamellae.  
(c) Hair follicles are the most important appendage in terms of surface area. This 
transfollicular route has been suggested as being significant particularly in the early 
stages of penetration (Hadgraft 1983). Iontophoresis appears to dramatically increase 
the flux of compounds through hair follicles (Schaefer and Redelmeier 1996b).  
 
No active transport process has been shown to be involved in skin permeation (Chien 1992). 
It also has to be mentioned that percutaneous absorption varies widely between individuals 
(Schaefer and Redelmeier 1996b). 
 
C.1.4 Metabolism of the skin 
 
In the last several years skin metabolism received more attention because evidence grew 
that skin is not only a barrier for passive diffusion but also an enzymatic barrier being 
capable of metabolizing drugs. That led to the fact that clearance by cutaneous metabolism 
can also be understood as another line of defense to shield the body from uptake of 
xenobiotics. Therefore skin metabolism may have a strong impact on transdermal delivery of 
drugs.  
Although the skin is well understood nowadays, the extent and the exact localization of 
enzyme activity remain still uncertain.  
 
C.1.4.1 Localization of the enzyme activity 
 
The viable epidermis and the dermis are sites of high metabolic activity. The epidermis 
contains many enzymes, which are necessary for the differentiation process in the viable 
layers.  The activity in the dermis is primarily associated with the sebaceous glands and the 
hair follicles. Sebaceous glands synthesize a complex series of lipids, whereas hair follicles 
synthesize large amounts of protein. 
Täuber and Rost (1987) demonstrated that incubated methylprednisoloneaceponate (MPA) 
with minced stratum corneum of hairless mice showed no degradation and supported the 
general meaning of stratum corneum being with its dead horny cells a metabolically inert 
layer. On the other hand they could detect a time-dependent decrease of MPA in minced 
dermis. They could also show that heat separated epidermis led to a lower metabolization 
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than epidermis separated by enzymes. This indicates that the enzymatic separation is more 
gentle and the activity of the enzymes is better preserved.  
Although a higher enzyme activity is found in skin appendages, the extent of their 
contribution to the overall skin metabolism is still unknown.  
The exact anatomic distribution of the enzyme systems also remains uncertain. High levels 
of testosterone-5α-reductase were found in scrotal skin, causing metabolism of testosterone 
to hydrotestosterone (Hsia and Hao 1996). On the other side, application of testosterone on 
the skin of, e.g., abdomen, chest, legs or arms appeared to be free of any metabolism 
(Mazer et al. 1992). 
 
C.1.4.2 Models for skin metabolism studies 
 
There are several in vitro models to study skin metabolism. Next to isolated cells, cell 
cultures and histochemical and immunohistochemical detection, the possibility to determine 
metabolism in homogenates or with mammalian skin fragments exists.  
Due to the resistance of the skin to homogenization, the harsh preparation required to disrupt 
the cells, may completely destroy the enzyme activities. 
Homogenization destroys compartmentation and the natural environment of the enzyme. So 
the metabolizing effect tested in skin homogenates may not directly reflect the mass 
transport and metabolism in organized tissue. 
There are different ways to investigate metabolism with mammalian skin fragments like 
isolated perfused porcine skin flap, full-thickness skin in organ culture and skin preparations 
in diffusion chambers (Steinsträsser and Merkle 1995). Here a defined area of skin is 
exposed to well-stirred donor and receiver compartment. It is also possible to organize the 
experiments under reflection boundary kinetics, e.g. the viable epidermis is side facing the 
donor chamber, whereas the receiver chamber is removed and replaced by an impermeable 
block resulting in reflection of both substrate and metabolite transport (Boderke et al. 1998). 
 
C.1.4.3 Inhibition of cutaneous metabolism 
 
Peptidase inhibitors 
 
Peptidases are enzymes, which catalyze the hydrolysis of proteins and peptides. They rarely 
show absolute specificity in their action, hence any peptidase has the potential to hydrolyze 
more than one substrate (Lee et al. 1991). The peptidases can be subdivided into two 
classes regarding their site of cleavage: endopeptidases, enzymes that cleave peptides and 
proteins at an internal peptide bond and exopeptidases that only cleave near the end of 
peptide chains. Exopeptidases are divided concerning their site of cleavage; for example 
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carboxypeptidase (removes a single amino acid from the C-terminus), peptidyl-dipeptidase 
(removes a dipeptide from the C-terminus), aminopeptidase (removes one amino acids from 
the N-terminus), dipeptidyl-peptidase (removes a dipeptide from the N-terminus) etc. 
Endopeptidases are further subdivided into subclasses based on their site of activity: serin-, 
cystein-, aspartic- and metalloproteases. But there are also endopeptidases of unknown 
enzymatic mechanism (Boderke 1998). 
 
Numerous agents could act as a peptidase inhibitor by a variety of mechanisms, e.g. by 
tightly binding to a covalent modification of the active sites of peptidases or by chelating the 
metal ions which are essential for the proteolytic activity. Chiang et al. (1998) tested 
inhibitors like o-phenanthroline, ethylenediaminetetraacetic, dilucine and sodium 
deoxycholate on the enzymatic stability of delta sleep-inducing peptide (DSIP). All four 
inhibitors could inhibit the degradation of DSIP to a certain extent in skin homogenate. By 
using 0.2 mM o-phenanthroline iontophoretic flux of DSIP was about three times as high as 
control (without inhibitor). The selection of an appropriate peptidase inhibitor could be guided 
by studying the principal peptidases responsible for the degradation of the peptide, their 
subcellular compartmentalization and the mechanism of the transport of the peptide (Banga 
and Chien 1993a). 
 
Temperature 
 
Higo et al. (1992) investigated the effect of skin storage and preparation on cutaneous 
metabolism of nitroglycerin. The skin was excised immediately postmortem and stored at 4°C 
for 10 days or put in a plastic bag and immersed in boiling water for 5 minutes. Storage at 
low temperature did not alter barrier function to the total nitrate flux whereas metabolic 
function was significantly impaired and suggested at least fivefold loss of the enzyme activity. 
Across heated skin total nitrate flux was significantly greater compared to the control 
membrane indicating damage on the skin barrier function. Additionally the ability to hydrolyze 
nitroglycerin was still present.  
Other groups could show inhibition of specific enzymes at temperatures below the freezing 
point (Kozlova-Lavrinenko and Sokolova 1976), at temperatures higher than 37°C 
(Smallridge et al. 1986) or inhibition of the enzyme activation at 81°C in the presence of 
metal ions by denaturation (Ilhan and Gulen 1993). 
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C.2 Transdermal iontophoresis: Theoretical model 
 
Iontophoresis is a method to enhance and regulate transdermal drug permeation and 
delivery by application of an electric field to the skin. 
The iontophoretic flux of a substance takes place by the following five mechanisms: 
 Passive diffusion 
 Direct effect of the electric field on ionized drug species (Nernst-Planck Equation) 
 Electroosmotic solvent flow which carries ions and neutral species  
      with the solvent stream  (modified Nernst-Planck Equation) 
 Permeation through aqueous versus lipid domains 
 Increase of the skin permeability by the electric field 
 
C.2.1 Passive diffusion 
 
Passive diffusion is a process, which can be described by the 1. Fick’s law. 
 
dx
dc
D
S
1
dt
dm
J  -==  
 
where J is the flux, m the mass, t the time, S the surface area of the skin and D the diffusion 
coefficient. The flux is directly proportional to the concentration gradient dc/dx. 
For diffusion through a membrane with a thickness h and a donor concentration cD, the 
partition coefficient K between membrane and donor/receiver solution must be introduced. 
 
DD Pcch
DKJ ==  
 
The same composition of the donor and the receiver solution, a homogeneous membrane 
and sink conditions (concentration in the receiver is zero and therefore negligible) are 
assumed under steady state conditions. 
 
The permeability coefficient P is a measure for the barrier function of the membrane for a 
specific substance. 
 
C.2.2 Nernst-Planck Equation 
 
Iontophoresis is a process, which involves movement of charged compounds through a 
membrane under the influence of an electric field. The Nernst-Planck Equation describes a 
model for a flux, driven entirely by an electrochemical potential gradient. 
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For iontophoretic transport across a membrane under steady state conditions at constant 
temperature, it is given by 
 
dx
d
RT
zFc
D
dx
dc
DJ
ψ
- -=  
 
where c is the concentration of the permeant at any point x in the membrane, D the diffusion 
coefficient, z the ionic valence of the permeant, F the Faraday constant , R the gas constant, 
T the absolute temperature and ψ the electric potential at any point x in the membrane. 
J is the same at all points in the membrane under steady state conditions. 
 
This model assumes that iontophoretic flux is driven entirely by the electrochemical potential 
gradient and ignores the contributions of current induced convective solvent flow and skin 
permeability increase due to alterations by the applied electrical potential gradient. 
 
C.2.3 Modified Nernst-Planck Equation incorporating convective solvent flow 
 
As consequence of the above made assumptions, the Nernst-Planck Equation predicts that 
the flux of uncharged molecules should not be affected by iontophoresis. However 
convective solvent flow comes to exist when electrical field is applied across a charged 
membrane (Gangarosa et al. 1980). To take this phenomenon into account, Nernst-Planck 
Equation was modified by Srinivasan and Higuchi (1990) to include a linear convective 
solvent term. 
 
c
dx
d
RT
zFc
D
dx
dc
DJ νψ ±- -=  
 
where c is the concentration of the permeant and ν the average velocity of the solvent. If the 
flux of the solvent takes place from donor to acceptor with the anode in the donor, ν is 
positive and contributes to the iontophoretic flux. If the solvent flux takes place from acceptor 
to donor, ν is negative. 
The enhancement factor E quantifies the change of permeation rate by the influence of 
voltage application across a membrane compared to passive diffusion. Theoretical E can be 
obtained from the modified Nernst-Planck Equation (Srinivasan and Higuchi 1990). 
 
( )PezBexp
PezB
−−
+−=
1
 E
 
where      
RT
F ψ∆
=B            and          
D
hν
=Pe  
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The Peclet number Pe is a dimensionless parameter, which characterizes the effect of the 
convective solvent flow. 
 
This model ignores the contributions of skin alterations caused by the applied 
electrochemical potential gradient. The same partition coefficients between membrane and 
donor and the same diffusion coefficient for passive and iontophoretic phase have been 
used. This indicates that permeation takes place through the same pathway under passive 
and iontophoretic conditions. 
 
C.2.4 Extended model incorporating lipid pathways 
 
This modification of the modified Nernst-Planck Equation takes into consideration the 
possible permeation through lipid pathways. Lütolf (1997) extended the model to induce the 
ratio of the permeability coefficients through lipid (Pld) and aqueous domains (Pad) under 
passive conditions. 
 
( ) 



+
+−−
+
+−
=
passive
adld
ad
passive
adld
ad
P/P
PeB zexp
)P/P(
PeB z
1
-1
1 
 E
 
 
This new model assumes that all ionic forms of a drug might permeate through aqueous and 
lipid domains, that the diffusion coefficient in the aqueous domain and in the lipid domain, 
respectively, is the same for all ionic forms and that the application of voltage does not effect 
permeation through the lipid domains. 
 
C.2.5 Extended model incorporating membrane alterations 
 
For all in this chapter described equations the contribution of membrane alteration during 
iontophoresis was ignored. For this reason, the ratio (ε’ / ε), where ε’ is the porosity arising 
due to voltage dependent alterations in the membrane and ε is the effective volume fraction 
of the aqueous domain under passive conditions and the ratio (Pld/Pad)passive’ under passive 
conditions after voltage application, was inserted (Kochhar and Imanidis 2003). 
( )
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C.3 Convective solvent flow 
 
Iontophoresis normally refers to the transfer of ionic solutes through biological membranes 
under the influence of an electric field. However, Gangarosa et al. 1980 have observed 
increasing transport of nominally neutral species by application of an electric field. Later work 
by Burnette and Marrero 1986 found enhanced transport of neutral thyrotropin releasing 
hormone and mannitol. 
 
When an electrical potential difference is applied at physiological pH across a ‘porous’ 
membrane containing fixed negative charges, i.e. ionic groups of lipids, fatty acids and 
cholesterol sulfate immobilized in the membrane, bulk fluid flow occurs in the direction of the 
anode to the cathode (anode in the donor) and implies a permselectivity to cations (Burnette 
and Ongpipattanakul 1987). 
 
C.3.1 Measurement of convective solvent flow 
C.3.1.1 Direct / Indirect methods 
 
Direct methods 
 
The effect of electroosmosis by applying constant current in vitro on human skin and 
measuring the flow rate of water was first described by Rein in 1924. He measured the 
increase in the volume of the acceptor and determined the flow rate by measuring the 
number of drops falling down per unit time in horizontal position. 
By measuring the fluid movement flow in horizontal capillary tubes attached to the anode and 
cathode compartments by Pikal and Shah 1990a, the convective solvent flow was 
investigated as a function of pH. The measurements showed pH dependence consistent with 
the charge on the membrane. 
 
Indirect methods 
 
Different groups have investigated the convective flow with the help of the indirect method by 
measuring the rate flow of an uncharged molecule like mannitol. It could be shown that 
iontophoretic flow of mannitol through human skin is increased in comparison to passive 
diffusion, if the anode is in the donor chamber and the skin carries a net negative charge 
(Sims et al. 1991). These experiments were carried out at 125 mV and 250 mV, where 
membrane alterations are not supposed to play any role. 
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Electroosmotic flow from anode to cathode increased the flux of an uncharged molecule with 
applied current density and led to a flux decrease in cathode to anode direction (Delgado-
Charro and Guy 1994). 
Another study was carried out to show that at physiological pH lipophilic and positively 
charged drug species can neutralize the skin charge and therefore decrease or even change 
the direction of the convective solvent flow (Hirvonen et al. 1996). 
 
C.3.2 Permselectivity of the skin 
 
The isoelectric point (pI) of the skin is above 4 (Hoogestraate et al. 1994, Luzardo-Alverez et 
al. 1998, Marro et al. 2001) and at physiological pH the skin is a negatively charged 
membrane. This net negative charge may result from a greater number of residues of protein 
amino acids, fatty acids and ceramides carrying negative charges (e.g. carboxylic groups) as 
opposed to positive charges (e.g. amine moieties). 
This characteristic implies that the skin allows the transport of a positively charged 
compound to proceed with less resistance than the transport of a comparable-sized 
negatively charged compound (Burnette and Ongpipattanakul 1987). 
 
Direct proof of this permselectivity was given by measuring passive and iontophoretic 
transport of Na+, Cl- and mannitol across human cadaver skin at pH 7.4 (Burnette and 
Ongpipattanakul 1987). When the anode was placed in the donor compartment containing 
Na+ and Cl-, the flux of the anion detected in the receptor compartment containing the 
cathode was approximately three orders of magnitude smaller than the flux of the cation. In 
consequence an osmotic flow with a convective movement of the dissolved mannitol occurs 
from the anode to the cathode chamber. The permselectivity of the skin was also confirmed 
by other authors using monovalent ions like sodium, potassium and caesium and divalent 
ions like calcium, magnesium and zinc (De Nuzzio and Berner 1990). 
 
The convective solvent flow can be influenced by different factors, which are discussed in the 
following chapter. 
 
C.3.3 Factors affecting convective solvent flow 
C.3.3.1 Molecular weight of the permeant 
 
For large peptides (molecular weight ≥1000 Da), electroosmosis is a significant mechanism 
for iontophoretic enhancement because the fraction of the total current carried by the 
molecule is very small compared to smaller, more mobile ions which are typically present, 
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either comprising part of the peptide formulation (e.g. the buffer), or as endogenous ions 
within and beneath the cutaneous barrier (Marro et al. 2001). 
 
The influence of permeant molecular weight was determined by analyzing the electroosmotic 
flux enhancement of urea, mannitol, sucrose and raffinose (molecular range of 60-504). The 
flux enhancement due to electroosmosis was strongly molecular weight dependent, e.g. the 
Peclet number was around 4 times greater for raffinose than for urea, and mannitol and 
sucrose yielded intermediate values. The calculated effective flow velocity showed a linear 
correlation to the applied voltages of 125, 250, 500 and 1000 mV but was independent of the 
molecular weight of the permeant. These observations showed a semi-quantitative 
agreement between the predictions of the model and the experimental results (Peck et al. 
1996). 
 
C.3.3.2 Structure of the permeants 
 
Numerous studies have investigated the neutralization of the net negative charge of the skin. 
It has been suggested that a positively charged peptide like the leutinizing hormone releasing 
hormone (LHRH) (Delgado-Charro and Guy 1994), leuprolide (Hoogestraate et al. 1994, 
Kochhar and Imanidis 2003) and also nafarelin (Delgado-Charro and Guy 1994) may be able 
to reduce, neutralize or even reverse the negative charge of the membrane and decrease or 
change the direction of the electroosmotic flow. 
This reversal of the direction implies that at physiological pH (the anode in the donor 
compartment) the convective solvent flow would impede the flux of a positively charged and 
neutral permeant and assist the flux of a negatively charged permeant. 
It was shown that the degree of effect was correlated with the initial concentration but also 
with the molecular size of the permeants employed (Hirvonen and Guy 1998). 
The necessity of the presence of a positive charge in close proximity to a hydrophobic 
portion of the molecule is not clearly defined yet. Studies investigating the effect of LHRH, 
nafarelin and oligopeptides with different degree of lipophilicity, on the direction of the 
electroosmotic flow, showed clearly the need of a hydrophobic surface (Hirvonen et al.1996). 
The same effect was shown by delivering β-blockers of different lipophilicity (Hirvonen and 
Guy 1997). 
On the other hand, experiments with tripeptides which differed only in the central amino acid 
residue and thus in the charge and relative lipophilicity were carried out and resulted in an 
independence of the permeant lipophilicity (Green et al.1991). 
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Studies investigating the influence of divalent ions on electroosmosis such as Ca2+ (Burnette 
and Ongpipattanakul 1987, Santi and Guy 1996b) and Mg2+ (Santi and Guy 1996b) showed 
a decrease of the electroosmotic flow by these ions. Shielding of the net negative charge on 
the skin is a possible mechanism for this phenomenon, a hypothesis not inconsistent with the 
ability of certain lipophilic peptides to achieve a similar effect. 
 
Not only the inhibition of the electroosmotic flow by neutralizing the skin was investigated, but 
also the increase of the already negatively charged skin and thus to an enhanced 
electroosmotic flow (Hirvonen and Guy 1997, 1998). The experiments to enhance the 
negative charge of the membrane at pH 7.4 did not significantly improve cathodal extraction 
of negatively charged NSAIDs. The effect of poly-L-glutamic acids on mannitol flux was no 
more than a three fold increase. 
 
C.3.3.3 Current density and ionic strength 
 
Under constant current iontophoresis, anodal electrotransport of mannitol as a marker for the 
electroosmotic flow generally increases proportionally with current density. The 
electroosmotic flow is coupled with the linearly increased flow of ions, which takes place as 
the current density is raised. On the other hand, electroosmosis is decreased with increasing 
ion concentration at a constant current density (Pikal and Shah 1990b). 
The maximum electroosmotic flow may be increased by raising the current density is not 
known yet, but current densities of more than 0.5 mA /cm2 are regarded as inappropriate for 
human in vivo use (Delgado-Charro and Guy 1994). 
 
C.3.3.4 pH 
 
Lowering the pH of the compartment solutions near the pI of the skin results in a 
‘neutralization’ of the membrane, lowering under the pI in a positively charged membrane. 
This leads to a decrease or to a change of the direction of the convective solvent flow from 
the cathodal to the anodal compartment and thus to a permselectivity for anions. 
This change in skin charge was for example confirmed by measuring the mannitol flux at a 
pH range of 3.5 - 7.4. At physiological pH, mannitol flux dominated in the anode-to-cathode 
direction. By lowering the pH to 3.5 the direction of the convective solvent flow progressively 
reversed, indicating the skin becoming net positively charged (Marro et al. 2001).  
How much the direction of the electroosmotic flow may be changed by changing the pH is 
not known yet, but a pH lower than 3.0 is regarded as inappropriate for human in vivo use 
(Lopez et al. 2001). 
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C.4 Membrane alterations following iontophoresis 
 
Membrane alterations following the application of an electrical potential difference across a 
membrane contribute to an increased transport of charged and uncharged species. 
Sims et al. (1991 and 1992) investigated skin alteration effects during iontophoresis. 
Constant current during the application of 125 or 250 mV and the comparable permeability 
coefficient values before and after the voltage application showed that the membrane was 
not significantly altered. The application of 1000 mV on the other hand showed increasing 
current, sometimes different permeability coefficients before and after iontophoresis and a 
nonlinear increase of the amount of permeant transported across the membrane. Another 
group measured passive permeation rates before and after an application ≥ 500 mV, which 
did not completely return in the postiontophoretic phase to the baseline value (Kochhar and 
Imanidis 2003). 
Inada et al. 1994 monitored membrane alterations by measuring the electrical resistance. It 
was found that the rate of decrease in resistance was dependent upon the applied voltage 
that reversible recovery times are dependent upon the magnitude and the duration of the 
applied field and that recovery times were much longer when there were lower voltages 
applied over a longer range of time. 
Repeated iontophoretic application of 250 mV on the same skin piece was investigated with 
24 hours or 3 hours of passive phase between several voltage applications over 1 hour. The 
same enhancement and no membrane alterations could only be found with 24 hours of 
passive phase between the voltage applications (Kochhar and Imanidis 2003).  
 
It is now generally accepted that electrical breakdown of membranes is based on the 
formation of pores, so called pore induction, including pore modification like expansion of 
already existing pores. 
The magnitude and the duration of the applied voltage determine the quantity, reversibility 
and the size of the pore formation (Sims et al. 1992). 
Peck et al. (1994) measured effective pore radii of human epidermal membrane of 15-25 Å 
under passive conditions using urea, mannitol, raffinose and sucrose.  
Li et al. (1998) reported that the application of 2.0 V across human epidermal membrane 
resulted in a large porosity increase. The pore radii of the newly induced pores, calculated 
using the hindered transport theory, were found to be in the range of 6-12 Å. 
Higuchi et al. (1999) found pore radii of 10-20 Å by a new method, which incorporated the 
determination under steady electroporation conditions (low frequency (12.5 Hz) a.c. at 2-5 V) 
with hindered transport theory.  
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C.5 Reverse iontophoresis 
 
Iontophoresis is typically associated with drug delivery across the skin, but the symmetry of 
the technique permits its application to a noninvasive withdrawal of analytes from within the 
tissue to the body surface, so called reverse iontophoresis. This technique causes ions and 
neutral molecules to move in both directions under both electrodes (Glikfeld et al. 1989). 
 
This approach is used to monitor the subdermal concentration variations of glucose and 
provides therefore a noninvasive technique by which a diabetic might monitor the daily 
fluctuations in blood sugar (Rao et al. 1995). Although glucose is an uncharged molecule the 
passage of this polar sugar can be dramatically increased by electroosmosis. 
 
Another analyte of interest is the amino acid phenylalanine that is used to diagnose 
Phenylketonuria, a metabolic disease in infants resulting from a mutation in the gene 
encoding the enzyme phenylalanine hydroxylase. 
The reverse iontophoretic extraction was described as rapid, easily detectable and highly 
linear in the concentration range of 1-10 mM phenylalanine (Merino et al. 1999). 
 
Recently, investigations were carried out to replace therapeutic drug monitoring based on 
blood sampling by reverse iontophoresis. The results showed that the iontophoretic 
extractions flux of the investigated valproate was linearly correlated with the subdermal 
concentration (Delgado-Charro and Guy 2003). 
 
To optimize reverse iontophoresis, mannitol flux was measured as a function of pH, ionic 
strength and formulation (Santi and Guy 1996a, 1996b). It was found that cathodal extraction 
was enhanced by increasing the pH and reduced electrolyte ionic strength in the electrode 
chambers. An anodal composition with CaCl2 or MgCl2 instead of NaCl decreased 
electroosmotic flow towards the anode because of skin neutralization at pH 7.4. Hirvonen 
and Guy (1997, 1998) tried to increase the already negative charge of the skin at 
physiological pH to more negative values. The experiments to enhance the negative charge 
of the membrane at pH 7.4 by applying negatively charged NSAIDs did not significantly 
improve cathodal extraction. The effect of poly-L-glutamic acids on mannitol flux was no 
more than a three fold increase. 
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C.6 In vitro model used for permeation 
 
The advantage of in vitro compared to in vivo models is the possibility of varying parameters 
to a extent which is impossible in vivo. In vitro models offer also the advantages of being 
easier and convenient. 
Different models have been used to investigate the permeability of the membrane. But 
mostly two-chamber diffusion cells with a donor and an acceptor representing the delivery 
system and the body, respectively, have been used. 
 
C.6.1 Potentiostat used 
 
The four-electrode potentiostat system for a two-chamber diffusion cell, developed by 
Masada et al. 1985 and later modified and validated in our laboratory (Lütolf 1997), was used 
for the experiments. In this system each half cell has two electrodes, a counter electrode, 
dipped in the solution and a reference electrode, placed at one end of a Luggin capillary. 
The potentiostat maintains the potential drop across two Luggin capillary probes, which are 
placed very close to the membrane on either side, at a desired value by driving the required 
current through the cell with the help of the counter electrodes (Masada et al. 1989, 
Srinivasan et al. 1990). With this it is possible to control precisely and maintain constant the 
potential drop across the membrane. 
 
C.6.2 Diffusion cells 
 
The cells, with which the experiments were carried out, were of the horizontal type (see 
Figure 3 (Srinivasan et al.1990). 
 
Figure 3. Schematic drawing of one half-cell of the two-chamber diffusion cell 
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The Luggin capillary, which contains the reference electrode, consists of a long thin glass 
capillary placed very close to the membrane. It is filled with the same solution as in the two 
half cells. The use of this capillary eliminates any interfacial potential drops close to the 
membrane. With this, the voltage drop between the Luggin capillary tips corresponds to the 
potential drop of the membrane and can be controlled by driving the required current through 
the counter electrodes. 
 
 
Figure 4. A complete diffusion cell with Luggin capillaries, counter and reference electrodes 
and stirrers 
 
C.6.3 Electrodes 
 
The electrodes used to apply the potential difference across the skin should be inert, work at 
low voltage, provide a stable environment for the drug and the excipients and minimize the 
transport of toxic species to the skin (Teillaud 1997). Therefore Ag/AgCl electrodes were 
used. 
  
The electrochemical sequence of events is as follows: Na+ is repelled from the anode and 
enters the skin, leaving a charge imbalance in the solution surrounding the positive 
electrode. This is resolved by Cl-, which is attracted to the anode, combining with Ag to form 
AgCl, and releasing an electron to the electrical circuit: 
 
  Ag0(s)  +  Cl-(aq)  →  AgCl(s)  +  e- 
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In the cathodal compartment, the negative electrode attracts Na+ through the skin into the 
receptor phase. Again a charge imbalance is created, which is then resolved by dissociation 
of AgCl(s) from the electrode using an electron from the circuit: 
 
 AgCl(s)  +  e-  →  Ag0(s)  +  Cl-(aq)      
 
The net transfer of one Na+ (aq) and one Cl- (aq) from anode chamber to cathode chamber is 
effected. While the reverse movement of Cl- balances the above process, the permselectivity 
of the skin to Na+ dictates the net flow of ions as stated (Green et al. 1991). 
 
C.6.4 Membrane 
 
Difficulties in obtaining human skin lead to investigations of model-membranes, like hairless 
mouse and rat skin, skin of pigs and snakes and synthetic membranes like Nucleopore. 
 
With human skin, obtained from autopsies or following plastic surgery and stored at freezing 
temperatures, the best correlation between in vitro and in vivo is given. 
Because the stratum corneum plays the main role for the barrier properties of diffusion, heat 
separated epidermis has become a widely used model. Full thickness skin should be stored 
within 24 hours of demise at a temperature of the order of – 40 to –70°C. Studies showed no 
influence on the permeability of the skin after storage under -20°C (Barry 1983). After the 
modified method of Kligman and Christophers (1963) the full thickness skin, being freed of 
the fat, is heated in a waterbath at 60°C for 2 to 3 minutes and the epidermis peeled of the 
dermis. Later studies could have shown that good separation can also be achieved by 
heating the skin for just one minute (Sims et al. 1991). The barrier properties remain 
unaltered even after heating at 60°C over hours (Schaefer and Redelmeier 1996). 
 
C.6.5 The model substances 
 
The criteria for the selection of the model substances were peptide structure, same 
molecular weight, which should have been around 300 and a minimal solubility in Teorell-
Stenhagen buffer pH 3 and 4.5 of 0.5 mg/ml. 
At the same time the model substances, dissolved in Teorell-Stenhagen buffer pH 3, should 
carry a net positive charge, but they should differ regarding their partition coefficient. 
For detailed investigations of the convective solvent flow a substance with the same 
molecular weight and a minimal solubility of 1 mg/ml, but without carrying a charge at pH 3 
and 4.5, was needed. 
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Because of those criteria the following substances were chosen: 
 
Tyrosine-Phenylalanine (TyrPhe) 
Tyrosine-β-Naphthylamide (Tyrβ-NA) 
Benzyl-2-Acetamido-2-deoxy-α-D-glucopyranoside (BAd-α-Glc) 
 
Metabolism of peptides is typically catalyzed by enzymes such as aminopeptidase, 
carboxypeptidase and dipeptidase, which are metallopeptidases. Therefore, o-
phenanthroline, a metallopeptidase inhibitor, was chosen as inhibitor for cutaneous 
metabolism. 
 
C.6.5.1 Tyrosine-Phenylalanine 
 
Tyrosine-Phenylalanine (TyrPhe) is not therapeutically used and acts here as model 
substance. Chemically, it is a dipeptide and has the following structure: 
 
 
N
H
NH3OH
O
O
O
+
-
 
 
 
MW=328.4 
Bachem AG (4416 Bubendorf, Switzerland) 
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C.6.5.2 Tyrosine-β-Naphthylamide 
 
Tyrosine-β-Naphthylamide (Tyrβ-NA) is not therapeutically used and acts here as model 
substance. Chemically, it is an amino acid, which is blocked at the C-terminus with 
naphthylamide and has the following structure: 
 
NH
O
NH2OH
MW=306.4 
Bachem AG (4416 Bubendorf, Switzerland) 
 
C.6.5.3 Benzyl-2-Acetamido-2-deoxy-α-D-glucopyranoside 
 
Benzyl-2-Acetamido-2-deoxy-α-D-glucopyranoside (BAd-α-Glc), a glucose derivate, is a 
hydrophilic molecule, which acts in this work as an electroosmotic marker. 
 
 
O
OH
HOCH2
OH
NH
OCH2
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MW=311.3 
Toronto Research Chemicals Inc. (North York, Canada) 
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C.6.5.4 o-Phenanthroline HCl (Monohydrate) 
 
o-Phenanthroline, a metallopeptidase inhibitor, is used here to inhibit cutaneous metabolism. 
 
N+ N
H
Cl- x H2O
 
MW=234.69 
Fluka Chemie GmbH (9471 Buchs, Switzerland) 
 
C.7 Applications of iontophoresis 
 
The iontophoretic application of pilocarpine has been approved by the FDA for diagnosis of 
cystic fibrosis, a disease where the electrolyte concentration of the sweat is augmented. The 
increase of electrolytes has been used to stimulate the sweat secretion by pilocarpine and 
then to measure the electrolyte concentration (Gibson and Cooke 1959). 
 
Another diagnostic application is the non-invasive monitoring of diabetics blood glucose 
levels by reverse iontophoresis (Guy 1995). The wrist-watch, called 
GlucoWatchBiographer, received FDA approval in 1991. The watch extracts glucose 
through the skin by reverse iontophoresis and measures the extracted sample using an 
electrochemical biosensor. Although GlucoWatchBiographer measurements generally are 
consistent with those of traditional finger stick blood glucose tests, results can differ 
significantly. Because these variations are unpredictable, individual readings should never be 
used to make changes in insulin dose. Currently the GlucoWatchBiographer 
measurements must be used along with finger blood tests to ensure accurate results (FDA 
2002). 
 
The most classic use in clinical therapy of iontophoresis is the treatment of Hyperhydrosis, a 
disease of augmented sweat secretion. There are several anticholineric substances like 
poldinmetyhsulfate, glykopyrronium and atropin but also tap water, which proved to be 
effective. The hands or the feet are dipped in two basins, applied with a current of 20 mA. 
Although the mechanism of action in Hyperhydrosis is still unknown, this therapy has shown 
to yield satisfactory results. 
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Also commonly used in clinical therapy is the application of NSAIDs like diclofenac against 
inflammatory conditions like rheumatoid arthritis, local anesthetics like lidocaine, 
corticosteroids like dexamethasonnatriumphosphate, compounds against viral infections like 
Herpes simplex (idoxuridine) and like Papillomavirus (salicylate sodium) and cisplatin for the 
treatment of superficial carcinoma of the skin. 
 
An iontophoretic application of apomorphine in the systemic treatment of Parkinson has been 
investigated in clinical studies (Junginger 2002). 
Also the systemic treatment of hypertension was analyzed by an application of metoprolol 
(Okabe et al. 1986). 
 
Important for all these applications is a good cutaneous tolerance with as less as possible 
side effects. Generally speaking, iontophoresis is very tolerant and does not result in 
modifications of major physiological parameters (Guillot 1997). Even though there have been 
reported some side effects in literature like irritation, itching or pain and erythemas. Irritations 
are often related to pH changes that take place due to electrolysis of water by the use of 
metal/metal salt electrodes (Teillaud 1997). Itching and pain varies from one person to 
another and from different body locations, sometimes even from anode to cathode. 
Modification of the current density, the frequency and application time often reduces these 
side effects. The appearance of erythemas, which is due to the release of cytokines and 
prostaglandins that trigger vasodilatation, is reversible within hours (Thysman et al. 1995).  
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D Original publications 
 
 
D.1 Effect of cutaneous metabolism of a dipeptide on the iontophoretic flux of 
an uncharged electroosmosis marker 
 
Abstract 
 
Passive and iontophoretic transport of the dipeptide Tyrosine-Phenylalanine (TyrPhe) and a 
glucose derivative, Benzyl-2-Acetamido-2-deoxy-α-D-glucopyranoside (BAd-α-Glc), across 
heat-separated human epidermis in vitro was investigated at pH 3 and 4.5. TyrPhe and BAd-
α-Glc, an electroosmosis marker, were used separately and in combination. The influence of 
TyrPhe skin metabolism on its own permeation rate and skin retention as well as on the 
permeation rate and skin retention of BAd-α-Glc was examined. TyrPhe was found to be 
chemically and electrochemically stable. Incubation of TyrPhe with epidermis under reflection 
boundary conditions resulted in degradation of 12 % at pH 3.0 and 45 % at pH 4.5 over 70 
hours. No reproducible permeation of TyrPhe at pH 3 and no permeation at all at pH 4.5 was 
measured when the dipeptide was used alone or in combination with BAd-α-Glc. Additionally, 
higher fluxes of the degradation products Tyrosine (Tyr) and Phenylalanine (Phe) were 
observed and higher levels of Tyr and Phe were recovered from the epidermis compared to 
blank runs. Blank runs reflected endogenous levels of Tyr and Phe. Degradation was 
inhibited by the use of o-phenanthroline at pH 3 but not at pH 4.5 and at both pH values at 
low temperature (4°C). Inhibition was verified by reproducible TyrPhe permeation and blank 
level Tyr and Phe fluxes and tissue recovery. These results confirm degradation of TyrPhe 
by cutaneous metabolism in heat-separated human epidermis, that was stronger at pH 4.5 
compared to pH 3. BAd-α-Glc showed at both pHs smaller iontophoretic fluxes compared to 
the passive ones, indicating an electroosmotic flux from cathode to anode. In combination 
with TyrPhe, iontophoretic fluxes of BAd-α-Glc increased significantly when TyrPhe was 
metabolized in the tissue, while no such decrease was observed when TyrPhe metabolism 
was inhibited. This increase of BAd-α-Glc iontophoretic flux was accompanied by a 
considerable decrease of BAd-α-Glc amount retained in the epidermis. The generated Tyr 
and Phe appear, therefore, to decrease BAd-α-Glc amount retained in the epidermis and 
enhance iontophoretic flow. Thus, an interaction between the concurrent permeants at the 
level of tissue retention induced by metabolism can influence iontophoretic permeation of 
these poorly permeable compounds. 
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Introduction 
 
The skin, especially the stratum corneum, is an excellent barrier to the passive transport of 
topically applied drugs. Peptides penetrate the stratum corneum barrier with difficulty due to 
their hydrophilicity and large molecule size and due to the lipophilic nature of the stratum 
corneum. To overcome the problem of poor transport, the use of chemical and physical 
methods has been examined. Iontophoresis is a non-invasive process of increasing the 
permeation rate of charged and uncharged compounds into or through a membrane by the 
application of an external electric field across the membrane. The skin is a permselective 
membrane with an isoelectric point (pI) above 4 1,2,3, indicating a negative charge at 
physiological pH 4. This characteristic implies that the skin at physiological pH allows the 
transport of a positively charged compound to proceed with less resistance than the transport 
of a comparable-sized negatively charged compound. In consequence an osmotic flow with a 
convective movement of the dissolved permeants (charged and uncharged) occurs from the 
anode to the cathode chamber. Convective solvent flow is predominant during iontophoresis 
of neutral, polar compounds or compounds with a high molecular weight 5 - 7. Lowering the 
pH of the compartment solutions near the pI of the skin results in a neutralization of the 
membrane, lowering it under the pI in a positively charged membrane. This leads to an 
inhibition respectively to a change of the direction of the convective solvent flow from the 
cathodal to the anodal compartment and thus to a permselectivity for anions 1,8,9.  
Apart from the function as physical barrier the skin plays also an important role as metabolic 
barrier capable of degrading a wide range of substances upon permeation. Although the skin 
is well known nowadays, the extent and the exact localization of enzyme activity remains still 
uncertain. Cutaneous metabolism was found in epidermal as well as in dermal tissue10,12. 
The epidermis contains many enzymes, which are necessary for the differentiation process 
in its viable layers. In the stratum corneum a great variety of low-molecular-weight 
compounds such as amino acids and sugars may derive from metabolism19. The activity in 
the dermis is primarily associated with the sebaceous glands and the hair follicles. Detailed 
investigations resulted in lower metabolization in heat-separated epidermis than epidermis 
separated by enzymes13.  
 
In this report, separate and combined iontophoresis of the dipeptide Tyrosine-Phenylalanine 
(TyrPhe) and the glucose derivative Benzyl-2-Acetamido-2-deoxy-α-D-glucopyranoside 
(BAd-α-Glc), used as electroosmosis marker, across heat-separated human epidermis in 
vitro at pH 3 and 4.5 was investigated. A number of issues that influence iontophoretic 
transport of BAd-α-Glc were examined: (a) cutaneous metabolism of TyrPhe, (b) inhibition of 
TyrPhe metabolism, (c) electroosmosis and (d) skin retention. 
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Materials and Methods 
 
Materials 
 
Substances 
Tyrosine-Phenylalanine (TyrPhe) a dipeptide with a molecular weight of 328.4 and a pKa of 
3.5 was purchased from Bachem AG (Bubendorf, Switzerland). TyrPhe concentration used in 
the donor was 3 mM at pH 3.0 and 2 mM at pH 4.5. 
Metabolic degradation products of TyrPhe, Tyrosine (Tyr) with a molecular weight of 181.2 
(pKa 2.2, 9.1, 10.1) and Phenylalanine (Phe) with a molecular weight of 165.2 (pKa 2.2, 9.2) 
were purchased from Fluka BioChemika (Buchs, Switzerland) and Sigma Chemical CO (St. 
Louis, USA), respectively. The used donor concentrations for both amino acids were 3 mM at 
pH 3.0 and 2 mM at pH 4.5. 
Benzyl-2-acetamido-2-deoxy-α-D-glucopyranoside (BAd-α-Glc), neutral at all three pHs (3.0, 
4.5 and 7.2), was used as electroosmosis marker and added in a concentration of 13 mM to 
the donor solution. BAd-α-Glc (MW = 311.3) was purchased from Toronto Research 
Chemicals, North York, Canada.  
To inhibit cutaneous metabolism o-phenanthroline HCl (monohydrate), a metallopeptidase 
inhibitor, was used in a concentration of 0.5 mM at pH 3.0 and 4.5. The inhibitor was 
purchased from Fluka BioChemika (Buchs, Switzerland). 
 
Buffer 
Universal buffer was used at pH 3.0, 4.5 and 7.2. It was composed of citric and phosphoric 
acid (6.67 mM each), and boric acid (11.5 mM). They were all dissolved in double distilled 
water and the mixture was titrated to the desired pH using sodium hydroxide. For an 
osmolarity of 300 mosmol the adequate amount of sodium chloride was added to the donor 
and acceptor solutions. All the chemicals used were of analytical reagent grade or better. 
 
Skin 
The skin membrane used was human cadaver skin of only female donors, excised 
postmortemed within 24 h of demise from the abdominal region by the Department of 
Pathology, University Hospital, Basel. The membrane, which included the stratum corneum 
and a part of the epidermis, was separated from the underlying dermis by heat-
separation11,16.  
Preparation of the membrane, its fitting in the diffusion cell, a gravitational leaking and an 
electrical test of the membrane integrity, were made using the same procedures reported by 
Kochhar and Imanidis11.  
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Diffusion cells and iontophoretic equipment 
Custom-made glass diffusion cells connected to a four-electrode system developed in our 
laboratories11 were used for the permeation experiments. The anode was placed in the 
donor, the cathode in the acceptor compartment. 
The current source (built in the Department of Physics, University of Basel) supplied direct 
current only and could maintain voltage constant. While keeping voltage constant, the current 
was measured and recorded on a disk with Digital Chart Recorder (DCR 520, W + W 
Instruments AG, Basel, Switzerland). 
 
Methods 
 
Assay 
TyrPhe, the degradation products Tyr and Phe and BAd-α-Glc were assayed by LC/MS 
(Agilent 1100 and Hewlett Packard 1100 system). A chiral chromatography column (125 x 2 
mm, 5 µm, Spherisorb) was used for quantification. MS parameters were as followed: Mode: 
SIM, Polarity: Positive, Ionization mode: API-ES, Peak width: 0.2 min, Cycle time: 1.2 
s/cycle, Mass range: TyrPhe 329, Tyr 182, 204, 226, Phe 166, BAd-α-Glc 312, Fragmentor: 
40-80 Volt, Drying gas flow: 10l/min, Nebulizer pressure: 30 psig, Drying gas temperature: 
350°C, Capillary Voltage: 4000, mobile phase: acetonitrile 5%, double distilled water 95%, 
ammonium acetate 10 mM and acetic acid 50% to pH 3.2 
Benzyl alcohol to determine the stability of BAd-α-Glc was analyzed by HPLC (Hewlett 
Packard 1100 system; ICC 125/2 Lichrospher 100-5 RP-18ec). HPLC parameters were as 
followed: Wavelength: 258 ηm, mobile phase: acetonitrile 15% and double distilled water 
85%. 
 
Protocol of permeation experiments 
A typical experiment involved three experimental stages. Passive I was a passive stage over 
44 hours during which steady state permeant flux was measured by collecting samples of 
0.2 ml every 90 minutes from the receiver chamber. The volume was replenished with fresh 
buffer. During three hours a fixed voltage of 250 mV was applied across the membrane. 
Samples of 0.2 ml were taken every 20 minutes from the receiver chamber and replaced with 
0.2 ml fresh buffer. Passive II was a second passive run over 22 hours taking samples of 
0.2 ml every 90 minutes from the receiver chamber and replacing them with 0.2 ml fresh 
buffer. All the samples were analyzed with no previous treatment against a set of standard 
solutions by LC/MS. At the beginning of each stage 0.05 ml were taken of the donor chamber 
and not replenished. These samples were diluted 400 fold before analyzed. 
At the end of Passive I and II a voltage drop of 250 mV was applied for 5 minutes to record 
the electrical resistance and to check the integrity of the barrier. At the end of each 
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experiment the absence of significant pH and osmolarity changes in both chambers was 
verified. 
The cumulative amount of the substances permeating the membrane was determined as a 
function of time. Fluxes for TyrPhe and BAd-α-Glc were determined during each 
experimental stage and for Tyr and Phe during the whole experiment. 
 
Protocol of permeation experiments with inhibition 
The enzyme inhibitor o-phenanthroline was added in a concentration of 0.5 mM to the donor 
and the receiver solution to determine the effect of inhibition on skin enzyme activities and 
thus on the degradation of TyrPhe. The same procedure as described above was carried out. 
As a second method the above described experiments were carried out at 4°C15 instead of 
37°C. 
 
Stability of TyrPhe 
During passive and iontophoretic phase peptide breakdown via chemical, electrochemical or 
enzymatic degradation may be envisaged. Therefore experiments were undertaken to 
determine whether theses reactions, and to what extent, were occurring. To determine 
chemical stability 4 mM solutions of TyrPhe at pH 3.0 and 4.5 were shaken continuously by 
magnetic stirrer at 37°C over a period of 95 hours. Samples were withdrawn every 10-12 
hours. 
75 membrane filters (Isopore Membrane Filter, Filter Type 0.1 µm VCTP, Milipore AG) with 
a pore size of 0.1 µm were used instead of human epidermal skin to investigate 
electrochemical degradation of TyrPhe. Analogue to the permeation experiments a TyrPhe 
solution at pH 4.5 was used, but filled in both half-cells. During 8 hours a voltage of 250 mV 
was applied and each hour a sample was withdrawn. 
Reflection boundary set-up14 was performed to investigate cutaneous metabolism of TyrPhe. 
Therefore heat-separated epidermis, the viable epidermis facing the donor compartment, 
and, at the side of the stratum corneum, a plastic foil, as an impermeable barrier, were 
sandwiched between donor and receiver compartment (see Figure 1).  
All the samples withdrawn from these different stability experiments were analyzed with no 
previous dilution of TyrPhe and its degradation products Tyr and Phe by LC/MS. 
 
Stability of BAd-α-Glc 
1 ml of BAd-α-Glc solution (1.5 mM) was added to a piece of heat-separated epidermis of the 
same size like those of the permeation experiments. During 70 hours every 8-17 hours 
samples of 100 µl were withdrawn and analyzed as described above. 
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Skin extraction 
After each permeation experiment, the skin specimens were pulverized and extracted in 
order to determine the amount of the substances, which were dissolved in the donor solution 
and their possible degradation products, in the skin. The skin specimens were pulverized by 
a freezer mill, type 6750. The following settings were used for the pulverization: P Cool T3 
(freezing time 10 min), Run T1 (milling time 2-5 min), Cycles (1 cycle). After the milling the 
pulverized skin was dispersed in its HPLC eluant, put in the ultrasonic bath and centrifuged 
(10’000 rmp, 10 min). The over standing solution was then quantified for the corresponding 
substances and their possible degradation products by LC/MS.  
 
 
Results and Discussion 
 
Integrity of epidermal membrane 
 
The integrity of the epidermis during permeation experiments was monitored by continually 
measuring the electrical resistance of the membrane.  This was possible with the pair of 
reference electrodes and membrane reaching capillaries of the four-electrode power unit11.  
Monitoring membrane integrity was essential because of the long duration of the 
experiments.  Electrical resistance is a sensible measure of integrity because it is 
immediately related to the permeation barrier function of the epidermis and is quite sensitive 
because it responds to changes of the permeation of small electrolyte ions through the 
membrane.   
In Figure 2, membrane resistance during the three hours of iontophoresis is shown for 
several epidermis specimens encompassing different experimental conditions.  Typically, the 
resistance remained constant or showed a small decline.  In absolute terms, membrane 
resistance values varied between 20 and 150 kOhm*cm2, the majority being around 40 
kOhm*cm2.  These values are in agreement with the established electrical resistance of 
human epidermis in isotonic electrolyte solution.  Experiments that did not comply with this 
resistance pattern were discarded.  These results demonstrate that it was possible to 
guarantee the integrity of the epidermis under the present experimental conditions.   
 
Permeation and metabolism of TyrPhe 
 
In Table 1, the passive and iontophoretic fluxes of the dipeptide TyrPhe and the amount of 
the amino acids Tyr and Phe detected in the receiver compartment of the diffusion cells are 
reported.  The amino acid amount increased steadily during the permeation experiment, but 
no uniform distinction in the pattern between passive and iontophoretic stages could be 
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made.  Therefore, the amino acid results are reported as average fluxes over the entire 
experimental duration. 
No reproducible permeation of TyrPhe was measured at pH 3 when the dipeptide was used 
alone (not shown) or in the presence of BAd-α-Glc.  TyrPhe was either not detectable at all 
or it first appeared in the receiver at time points that varied strongly between experiments.  
Under the same conditions at pH 4.5, TyrPhe permeation was never detectable.  In the same 
experiments, the amount of amino acids measured in the receiver solution was elevated 
compared to the blank runs.  It is worth noticing here that a significant amount of 
endogenous Tyr and Phe is released from the epidermis in the blank runs.  The elevated 
amino acid amounts suggest that the failure to detect dipeptide fluxes was because of 
hydrolytic cleavage of its peptide bond, whereby the constituent amino acids are formed.  No 
amino acids were detected in the donor solution either because of the strong dilution of this 
solution prior to the assay or because of limited diffusion through the stratum corneum.  
Analysis of the epidermis specimens at the end of the experiment confirms the above view 
(Table 2).  Intact TyrPhe was recovered from the epidermis when it was used alone or in the 
presence of BAd-α-Glc at both pH values demonstrating that the dipeptide penetrates into 
the tissue.  The levels of Tyr and Phe were again higher compared to those of the blank runs 
indicating hydrolysis of TyrPhe. 
TyrPhe was found to be chemically stable under the employed experimental conditions.  
Also, electrochemical stability was verified after application of a voltage of 250 mV for eight 
hours to the solution (data not shown).  These results provide evidence that degradation of 
TyrPhe in the epidermis takes place by enzymatic hydrolysis.  The presence of peptidases in 
the epidermis has already been reported in the literature12.   
The enzymatic degradation of TyrPhe was quantitatively assessed by incubations with 
epidermal membrane using the reflection boundary experimental arrangement (Figure 1).  A 
decrease of TyrPhe concentration was evident, which was stronger at pH 4.5 than at pH 3 
(Figure 3).  BAd-α-Glc included as a control showed a marginal concentration change.  In 
separate incubation experiments of BAd-α-Glc with epidermal membrane, the generation of 
<0.5% benzyl alcohol, the product of glycosidase action on this glucose derivative, in 70 
hours was found for both pH values, confirming that under these conditions this compound 
was practically stable.  The mass balance of the enzymatic TyrPhe reaction is given in Table 
3.  A three-fold greater decrease of concentration was observed at pH 4.5 compared to pH 3.  
The amount of generated Tyr and Phe accounted exactly for the concentration decrease of 
TyrPhe after correction for the endogenously produced amino acids. 
From these results, substantial metabolism of TyrPhe in human cadaver epidermis can be 
concluded.  The lack of measurable transdermal permeation of this dipeptide is therefore the 
result of its metabolism in the epidermis.  This is more pronounced at pH 4.5 than at pH 3 
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probably reflecting a difference of enzymatic activity between these two pH values.  The 
amount of the amino acids Tyr and Phe recovered from the tissue at the end of the 
permeation experiments was, when related to the dipeptide, larger at pH 4.5 than at pH 3; 
this is in agreement with the more pronounced metabolism at the former pH compared to the 
latter.  The consistently not detectable permeation at pH 4.5 and the in this respect more 
variable result at pH 3 can also be ascribed to this difference of enzymatic activity between 
the pH values, considered on average over all skin specimens.  Finally, Tyr seems in general 
to be more abundant than Phe, which is possibly because of conversion of Phe to Tyr by 
enzymatic hydroxylation. 
The metabolism of TyrPhe is potentially catalyzed by enzymes such as dipeptidase, 
carboxypeptidase and aminopeptidase that have been found in the epidermis15.  These are 
typically metalloenzymes.  Therefore, the addition of o-phenanthroline, a chelating agent, 
was investigated as a means to inhibit degradation.  At pH 3, it was possible to inhibit 
enzymatic cleavage of TyrPhe by 0.5 mM o-phenanthroline as indicated by the reproducible 
permeation across epidermis (Table 1) and the nearly blank levels of Tyr and Phe extracted 
from the tissue (Table 2).  At pH 4.5, however, lacking epidermal permeation and elevated 
tissue levels of Tyr and Phe demonstrate that, at least at this concentration, addition of o-
phenanthroline could not inhibit hydrolysis of TyrPhe.  This seems to be in line with the 
stronger metabolism at pH 4.5 compared to pH 3 discussed above.   
Metabolic degradation of TyrPhe at both pH values was completely suppressed at 4°C.  This 
is evidenced by the amounts of Tyr and Phe found in the receiver solution and recovered 
from the epidermis, that were all at the level of the blank runs.  Furthermore, TyrPhe 
permeation was measured in a reproducible fashion and the amount of intact TyrPhe 
extracted from the tissue was higher compared to the other experiments at the same pH.  
Therefore, iontophoresis of TyrPhe could be studied only at this low temperature.  Flux and 
epidermal accumulation of TyrPhe as well as the difference of iontophoretic permeation 
enhancement between the used pH values are addressed elsewhere17.  The present results 
reassert that the epidermis exhibits marked metabolic activity even under in vitro conditions 
and can elicit considerable first pass drug metabolism in dermal and transdermal delivery. 
 
Iontophoresis of BAd-α-Glc 
 
BAd-α-Glc, a glucose derivative, is used as a reporter of electroosmotic flow in the 
iontophoresis experiments. Frequently, poly-alcohols such as mannitol being highly 
hydrophilic and electrically neutral molecules, have been employed for this purpose.  In 
BAd-α-Glc, glucose is substituted with a benzyl group making the compound detectable by 
UV spectroscopy. The n-octanol/aqueous buffer partition coefficient of BAd-α-Glc was found 
to be 0.110 and 0.133 at pH 4.5 and 3, respectively17, confirming that the compound was 
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quite hydrophilic thus warranting its use as electroosmosis marker. Also, BAd-α-Glc is not 
subject to glucolysis because of its 2-substitution and is stable towards epidermal 
glycosidase as shown above. Finally, the pKa of the acetyl-amino group is typically around 
unity, which renders the compound practically uncharged at the employed pH values but 
enables its detection by positive mode electrospray mass spectroscopy. 
Passive epidermal permeability of BAd-α-Glc was inversely proportional to the electrical 
resistance of the membrane regardless of pH as demonstrated in Figure 4.  This behavior 
has also been observed for other hydrophilic molecules11,18. This relationship was used to 
correct for skin-to-skin variability by referring all passive flux values to a membrane 
resistance of 60 kOhm*cm2 (Table 4). No difference in (adjusted) passive permeability 
between pH 3, 4.5 and 7.2 was observed within experimental error as would be expected for 
an unionized compound. The presence of o-phenanthroline or TyrPhe individually did not 
seem to affect passive BAd-α-Glc fluxes while their combination might have caused a 
reduction of passive flux; the present data basis, however, is not broad enough to allow a 
definite conclusion in this respect. Also, no systematic effect of temperature could be 
observed after the correction based on the 4°C electrical membrane resistance. 
The effect of iontophoresis on BAd-α-Glc is evaluated by comparing iontophoretic fluxes with 
the corresponding (raw, i.e., unadjusted) passive fluxes. Iontophoretic flux at pH 7.2 was 
higher than the passive one, this being in line with the established notion that at this pH 
electroosmotic flow takes place in the anode-to-cathode direction due to the negative fixed 
charges of the epidermal membrane. At pH 4.5 and pH 3, iontophoretic fluxes were 
diminished compared to the passive ones, which is consistent with a cathode-to-anode 
direction of electroosmotic flow and the proposed isoelectric point of human epidermis of 
between 4.5 and 51,2. At pH 3, in particular, the average iontophoretic fluxes given in Table 4 
are the result of partly positive and partly negative values of the individual experiments.  
Negative flux values reflect a reduction of the permeant concentration in the receiver 
compartment. This is a remarkable result indicating that the magnitude of the electroosmotic 
flow was such that it prevailed over the flux due to the concentration gradient between donor 
and receiver compartment.   
The presence of TyrPhe in the donor solution had a striking effect on the iontophoresis of 
BAd-α-Glc. At both, pH 3 and pH 4.5, iontophoretic fluxes were invariably several fold higher 
than passive fluxes contrary to the result obtained when BAd-α-Glc was used alone. Given 
the fact that TyrPhe was metabolized in the epidermis, the question arose of whether TyrPhe 
itself or its metabolic products were responsible for this effect. For the donor compositions 
BAd-α-Glc+TyrPhe pH 3, BAd-α-Glc+TyrPhe pH 4.5, and BAd-α-Glc+TyrPhe+o-
phenanthroline pH 4.5, a flux enhancement, whereas for all other compositions a flux 
retardation of BAd-α-Glc was achieved by iontophoresis. For the first group of the three 
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compositions, a hydrolysis of TyrPhe to Tyr plus Phe was found (previous section) whereas 
for all other compositions this hydrolysis was inhibited by the low temperature or (at pH 3) by 
the addition of o-phenanthroline. o-phenanthroline itself did not affect the iontophoretic 
behavior of BAd-α-Glc (Table 4). These results clearly demonstrate that the generation of the 
amino acids Tyr and Phe, but not the dipeptide, must be responsible for the change of the 
effect of iontophoresis on BAd-α-Glc flux.   
The iontophoretic enhancement of BAd-α-Glc observed at pH 3 and pH 4.5 when TyrPhe 
was hydrolyzed to Tyr and Phe might at first be interpreted in terms of the electroosmotic 
flow taking place in the anode-to-cathode direction. This would entail that the amino acids 
reversed the direction of the flow in this pH range by shifting the isoelectric point of the 
epidermis towards lower values. This has been reportedly accomplished by negatively 
charged compounds which bound to the tissue7,11. Tyr and Phe, however, are unlikely to be 
exerting this effect because they are partly positively charged at the pH range of interest.   
A mechanistic understanding of the observed phenomenon may be gained by considering 
the accumulation of the compounds in the epidermis (Table 2). For all donor compositions 
which produced no Tyr or Phe, including BAd-α-Glc alone, and which gave a cathode-to-
anode electroosmotic flow at pH 3 and 4.5, the amount of BAd-α-Glc recovered from the 
tissue was high with an average of >20 µg per specimen. Also for pH 7.2 and anode-to-
cathode electroosmotic flow but no Tyr or Phe production, a high tissue content of BAd-α-Glc 
was found. For the other compositions, the recovered amount was reduced to less than half 
of this value. It appears, therefore, that the generated Tyr and/or Phe decreased the amount 
of BAd-α-Glc retained in the epidermis. Since the amount of permeants accumulating in the 
epidermis is significant compared to the amount permeating into the receiver solution, a 
variation of the former can influence the determined flux values.   
These results suggest that the apparent iontophoretic permeation enhancement of BAd-α-
Glc at pH 3 and 4.5 is due to a promoted release of this compound from the epidermis into 
the receiver compartment rather than an anode-to-cathode electroosmotic flow. The 
mechanism by which, firstly, BAd-α-Glc binds to the epidermis and, secondly, it is displaced 
by Tyr and/or Phe is scantly understood. Nevertheless, some interesting characteristics of 
the process may be pointed out: (i) the endogenously present Tyr and Phe, representing one 
third to one half of the total amino acid amount recovered from the tissue, do not seem to 
produce the same effect; (ii) the dipeptide TyrPhe does not produce the effect of Tyr and 
Phe; (iii) importantly, displacement of BAd-α-Glc by Tyr and/or Phe is promoted by 
iontophoresis; (iv) the release of BAd-α-Glc into the receiver solution outweighs by far the 
cathode-to-anode electroosmotic flow taking place in this pH range for determining the 
apparent iontophoretic permeation of the compound. Examining this property of the amino 
acids prospectively using different permeants is subject of subsequent investigations17. 
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Conclusions 
 
The dipeptide TyrPhe is extensively metabolized in the epidermis. The generated metabolic 
products Tyr and Phe enhance iontophoretic transport at pH 3 and pH 4.5 of the glucose 
derivative BAd-α-Glc used as an unionized electroosmosis marker. This appears to take 
place by an interference of the amino acids with the distribution and/or binding process of 
BAd-α-Glc in the epidermal tissue during iontophoresis. The results underline the possibility 
of permeability interactions in iontophoretic delivery between permeants or the products of 
their cutaneous metabolism.   
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Table 1. Flux, J, of TyrPhe, Tyr and Phe at pH 3.0 and 4.5 with Standard Error of  
the Mean, SEM, (n=2-8) 
J of TyrPhe and SEM x 106 (in ug/s/cm2) J69h
d of Tyr and Phe and 
SEM x 106 (in ug/s/cm2) pH Donor composition 
Passive I Iontophoresis Passive Ie Tyr Phe 
3.0 TyrPhe + BAd-α-Glc ND a ND a ND a 1.87 (0.40) 
1.67 
(0.11) 
3.0 TyrPhe + BAd-α-Glc + Phenanthroline 
1.11 
(0.48) 
3.04 
(2.49) 
0.95 
(0.44) NM
 b NM b 
3.0 TyrPhe + BAd-α-Glc  at 4°C 
1.33 
(0.32) 
2.31 
(0.94) 
1.08 
(0.36) 
1.21 
(0.21) 
0.92 
(0.13) 
3.0 Blank NA c NA c NA c 1.02 (0.23) 
0.74 
(0.012) 
4.5 TyrPhe + BAd-α-Glc ND a ND a ND a 3.17 (1.06) 
1.27 
(0.43) 
4.5 TyrPhe + BAd-α-Glc + Phenanthroline ND
 a ND a ND a NM b 0.93 (0.20) 
4.5 TyrPhe + BAd-α-Glc  at 4°C 
2.69 
(1.69) 
1.08 
(0.77) 
1.01 
(0.37) 
1.94 
(0.53) 
0.72 
(0.11) 
4.5 Blank NA c NA c NA c 1.91 (0.21) 
0.84 
(0.14) 
a ND - not detectable 
b NM - not measured 
c NA - not applicable 
d Flux over 69 hours 
e Flux of Passive I phase interpolated to a membrane resistance of 60 kOhm*cm2. 
Regression through the points gave a slope of –1.04 and r=0.67 for pH 3.0 and 4.5. 
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Table 2. Skin extractions of permeation experiments with different donor compositions,  
temperatures and pHs with Standard Error of the Mean, SEM, (n=3-11) 
Amount ug/skin sample (SEM) 
pH Donor composition 
TyrPhe Tyr Phe BAd-α-Glc 
3.0 TyrPhe + BAd-α-Glc 4.96 (0.60) 2.39 (0.71) 2.54 (0.81) 4.97 (1.67) 
3.0 TyrPhe + BAd-α-Glc + Phenanthroline 
10.20 
(0.61) 
1.20 
(0.49) 
1.23 
(0.63) 
21.48 
(3.82) 
3.0 TyrPhe + BAd-α-Glc at 4°C 
9.40 
(1.08) 
1.10 
(0.32) 
0.94 
(0.61) 
17.90  
(3.98) 
3.0 TyrPhe 4.23 
(1.40) NM
 a NM a NA b 
3.0 BAd-α-Glc NA b NM a NM a 22.43 (4.18) 
3.0 Blank (4°C + 37°C) NA b 1.02 (0.50) 
0.90 
(0.40) NA
 b 
4.5 TyrPhe + BAd-α-Glc 1.66 (0.93) 4.04 (0.87) 3.27 (1.10) 7.48 (1.21) 
4.5 TyrPhe + BAd-α-Glc + Phenanthroline 
0.94 
(0.40) 
3.90 
(1.20) 
4.10 
(1.60) 
12.50 
(4.70) 
4.5 TyrPhe + BAd-α-Glc at 4°C 
2.80 
(0.18) 
1.93 
(0.65) 
1.53 
(0.38) 
22.63 
(5.20) 
4.5 BAd-α-Glc NA b NM a NM a 24.10 (5.18) 
4.5 Blank (4°C + 37°C) NA b 1.45 (0.50) 
1.06 
(0.43) NA
 b 
7.2 BAd-α-Glc NA b NM a NM a 22.53 (5.84) 
a  NM not measured 
b  NA not applicable 
 48
Original Publications 
_________________________________________________________________________________ 
 
 
Table 3. Enzymatic degradation of TyrPhe (reflection set-up) after 70 hours with  
Standard Error of the Mean, SEM, (n=3-4) 
pH  
degraded 
concentration 
in µM 
measured 
concentration 
in µM 
measured 
concentration 
in µM of blank 
experiments 
concentration 
in µM 
resulting from 
TyrPhe 
degradation 
3.0 TyrPhe 0.15 (0.034)    
3.0 Tyr  0.99 (0.023) 0.74 (0.035) 0.13 (0.023) 
3.0 Phe  0.85 (0.012) 0.69 (0.020) 0.16 (0.012) 
4.5 TyrPhe 0.55 (0.044)    
4.5 Tyr  1.53 (0.032) 0.86 (0.043) 0.67 (0.032) 
4.5 Phe  1.26 (0.024) 0.66 (0.023) 0.60 (0.024) 
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Table 4. Flux, J, of BAd-α-Glc with Standard Error of the Mean, SEM, at pH 3.0  
and 4.5 (n=3-9) 
J and SEM x 105 (in ug/sec/cm2) 
pH Donor composition 
Passive I Iontophoresis Passive Ia 
 
3.0 BAd-α-Glc + TyrPhe 
0.57 
(0.35) 
2.52 
(2.18) 
0.39 
(0.27) 
3.0 BAd-α-Glc + TyrPhe + Phenanthroline 
0.25 
(0.15) 
-0.057 
(0.055) 
0.065 
(0.019) 
3.0 BAd-α-Glc + Phenanthroline 3.67 (2.60) 
1.15 
(0.76) 
0.23 
(0.084) 
3.0 BAd-α-Glc + TyrPhe at 4°C 0.064 (0.018) 
0.039 
(0.047) 
0.035 
(0.0065) 
3.0 BAd-α-Glc 0.40 (0.11) 
0.20 
(0.32) 
0.57 
(0.28) 
4.5 BAd-α-Glc + TyrPhe 0.15 (0.030) 
0.69 
(0.25) 
0.30 
(0.026) 
4.5 BAd-α-Glc + TyrPhe
  + 
Phenanthroline 
0.063 
(0.012) 
0.22 
(0.074) 
0.043 
(0.012) 
4.5 BAd-α-Glc + TyrPhe at 4°C 2.61 (1.48) 
2.26 
(1.97) 
0.36 
(0.017) 
4.5 BAd-α-Glc 0.75 (0.35) 
0.41 
(0.16) 
0.40 
(0.12) 
7.2 BAd-α-Glc 4.13 (1.90) 
24.9 
(5.45) 
0.37 
(0.10) 
a Flux of Passive I phase interpolated to a membrane resistance of 60 kOhm*cm2 
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Figure 1. Reflection set-up consisting of donor compartment (left), heat separated epidermis 
(middle) and impermeable barrier (right; plastic foil). S, substrate; M, metabolite 
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Figure 2. Resistance course during iontophoretic phase (250 mV, 3 hours) of different 
permeation arrangements; the first three rows are experiments at pH 3, the last two rows at 
pH 4.5; x-axes show time in hours and y-axes the membrane resistance in kΩ*cm2 
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Figure 3. Reflection boundary set-up. Concentration decrease in % of  
TyrPhe and BAd-α-Glc over 70 hours at pH 3.0 and pH 4.5 with error bars  
showing SEM (n=4) 
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Figure 4. Correlation between Bad-α-Glc passive permeability and electrical resistance. Each 
point represents the data from one diffusion cell of a permeation experiment (♦ pH 3.0, ▲ pH 
4.5). Regression through the points gave a slope of –1.08 and r=0.70 for pH 3.0 and –1.09 
and r=0.86 for pH 4.5 
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D.2 Simultaneous assessment of tissue retention, lipophilicity of permeant 
and electroosmosis as factors affecting iontophoretic enhancement 
 
Abstract 
 
Passive and iontophoretic transport of the dipeptide Tyrosine-Phenylalanine (TyrPhe), the 
protected amino acid Tyrosine (Tyrosine-β-Naphthylamide (Tyrβ-NA)) and the glucose 
derivative, Benzyl-2-Acetamido-2-deoxy-α-D-glucopyranoside (BAd-α-Glc) across heat-
separated human epidermis in vitro was investigated at pH 3 and 4.5, at which the 
substances carried a positive or zero charge. The three substances were used separately or 
in combination. The influence of tissue retention and lipophilicity of the permeant and of 
electroosmosis on iontophoretic permeation was examined. A change of tissue retention 
affected iontophoretic enhancement. The presence of Tyrosine (Tyr) and/or Phenylalanine 
(Phe) elicited a decrease of BAd-α-Glc amount retained in the epidermis and an increase of 
iontophoretic permeation of BAd-α-Glc. The use of Tyr and Phe was motivated by a previous 
study (Altenbach et al. J Pharm Sci submitted). So far only Tyr and Phe were able to show 
this effect. Tyr and Phe did not affect iontophoretic permeation of TyrPhe and Tyrβ-NA. The 
effect of lipophilicity and electroosmosis was assessed simultaneously for all three 
permeants, which spanned a 70-fold range of lipophilicity, excluding the effect of extraneous 
Tyr and Phe. A theoretical model for the enhancement factor was used that was based on 
the modified Nernst-Planck Equation, extended by the ratio of permeability coefficients for 
lipid and aqueous pathway and including an estimate of the ionic valence of permeants in the 
aqueous domain of the tissue. At pH 4.5 a very weak electroosmotic flow from cathode to 
anode was observed, indicating an isoelectric point of the skin slightly above 4.5. At pH 3 
electroosmotic flow was approximately 10-fold stronger than at pH 4.5. The ratio of the 
permeability coefficients for lipid and aqueous pathways resulted for all compounds at both 
pHs in values much smaller than 1, indicating that the aqueous pathway dominated 
transepidermal permeation. The simultaneous analysis of the results of all substances shows 
that the applied model evaluation affords a quantitative assessment of the effect of ionic 
valence, lipophilicity and electroosmosis and makes possible to predict the outcome of 
iontophoresis. 
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Introduction 
 
Iontophoresis is an extensively investigated technology to enhance transdermal delivery of 
drugs by an electric field. Next to the direct effect of the electrical field driving ionic 
permeants into the skin, secondary phenomena such as electroosmosis and membrane 
alterations contribute to iontophoretic flux of charged and uncharged permeants.  
The direction of the electroosmotic flow may be with the current flow or against, depending 
on the nature of the membrane. The skin is a permselective membrane with an isoelectric 
point (pI) above 41,2,3. At physiological pH the membrane is negatively charged and 
electroosmotic flow contribute the current flow of an anodal delivery while cathodal delivery is 
retarded4,5. At a pH close to the pI of the membrane, a neutral membrane and therefore no 
electroosmotic flux occurs. At a pH smaller than the pI, the membrane carries a positive 
charge and the electroosmotic flow is against the current flow of an anodal delivery1,10,11. 
Compounds may permeate the skin through the aqueous and/or the lipid pathways12. The 
aqueous pathways are thereby responsible for the conductance of electric current. The 
importance of each pathway depends on the ionic state of the compound. Therefore 
iontophoretic permeation of a compound depends on its ionization. A model based on the 
modified Nernst-Planck Equation was expanded to include the relative permeation through 
lipid and aqueous domains of the skin13. 
 
In a previous paper7 the amino acids Tyrosine (Tyr) and Phenylalanine (Phe) appeared to 
decrease epidermis retention of the glucose derivative Benzyl-2-Acetamido-2-deoxy-α-D-
glucopyranoside (BAd-α-Glc), used as an electroosmosis marker, and increase thereby its 
iontophoretic delivery at pH 3 and 4.5. When BAd-α-Glc was present alone at the same pH 
values, iontophoresis elicited a flux retardation of this compound indicating electroosmotic 
flow occurring in the cathode-to-anode direction in accordance with the accepted view of 
positive fixed epidermis charges prevailing in this pH range.  In those experiments, Tyr and 
Phe were the products of the metabolism of the model dipeptide TyrPhe in the epidermis. 
The mechanism, by which the metabolic products of TyrPhe reduced the amount of BAd-α-
Glc retained by the tissue upon iontophoresis has not been adequately understood.   
In this paper the influence of Tyr and/or Phe on skin retention and iontophoretic permeation 
of the dipeptide Tyrosine-Phenylalanine (TyrPhe), the protected amino acid Tyrosine 
(Tyrosine-β-Naphthylamide (Tyrβ-NA)) and the glucose derivative Benzyl-2-Acetamido-2-
deoxy-α-D-glucopyranoside (BAd-α-Glc), which vary widely in their lipophilicity, was 
investigated. Permeation experiments were carried out across heat-separated human 
epidermis at pH 3 and 4.5. At those pH values TyrPhe and Tyrβ-NA are positively charged, 
whereas BAd-α-Glc is uncharged. A theoretical model for the enhancement factor was 
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applied to quantify the influence of lipophilicity and electroosmosis on iontophoretic 
enhancement. 
 
 
Materials and Methods 
 
Materials 
 
Benzyl-2-acetamido-2-deoxy-α-D-glucopyranoside (BAd-α-Glc), neutral at pH 3 and 4.5, was 
added in a concentration of 13 mM to the donor solution. BAd-α-Glc has a molecular weight 
of 311.3 and was purchased from Toronto Research Chemicals, North York, Canada. 
Tyrosine-β-Naphthylamide (Tyrβ-NA) an amino acid, which is protected at the C-terminus, 
with a molecular weight of 306.4 and Tyrosine-Phenylalanine (TyrPhe) a dipeptide with a 
molecular weight of 328.4 were purchased from Bachem AG (Bubendorf, Switzerland). pKa of 
TyrPhe and Tyrβ-NA was determined by potentiometric titration to be 3.50 and 4.78, 
respectively. TyrPhe and Tyrβ-NA concentration used in the donor was 3 mM at pH 3 and 2 
mM at pH 4.5. The amino acids Tyrosine (Tyr) with a molecular weight of 181.2 (pKa 2.2, 9.1, 
10.1) and Phenylalanine (Phe) with a weight of 165.2 (pKa 2.2, 9.2) were purchased from 
Fluka BioChemika (Buchs, Switzerland) and Sigma Chemical CO (St. Louis, USA), 
respectively. The used donor concentrations for both amino acids were 3 mM at pH 3 and 2 
mM at pH 4.5.  
Universal buffer was used at pH 3 and 4.5. It was composed of citric and phosphoric acid 
(6.67 mM each), and boric acid (11.5 mM), which were all dissolved in double distilled water 
and titrated to the desired pH using sodium hydroxide. For an osmolarity of 300 mosmol the 
adequate amount of sodium chloride was added to the donor and acceptor solutions. All the 
chemicals used were of analytical reagent grade or better. 
 
Human skin was obtained from the Department of Pathology, University Hospital, Basel. 
Heat-separation of the skin, the fitting in the diffusion cell, a gravitational leaking test and an 
electrical test of the barrier properties were carried out as described in6.  
 
Custom-made glass diffusion cells connected to a four-electrode system developed in our 
laboratories6 were used for the permeation experiments. The anode was placed in the donor, 
the cathode in the acceptor compartment. 
The current source (built in the Department of Physics, University of Basel) supplied direct 
current only and could maintain voltage constant. While keeping voltage constant, the current 
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was measured and recorded on a disk with Digital Chart Recorder (DCR 520, W + W 
Instruments AG, Basel, Switzerland). 
 
Methods 
 
Assay 
Tyr, Phe, BAd-α-Glc, Tyrβ-NA and TyrPhe were assayed by LC/MS (Agilent 1100 and 
Hewlett Packard 1100 system). A chiral chromatography column (125 x 2 mm, 5 µm, 
Spherisorb) was used for quantification. MS parameters were as followed: Mode: SIM, 
Polarity: Positive, Ionization mode: API-ES, Peak width: 0.2 min, Cycle time: 1.2 s/cycle, 
Mass range: Tyr 182, 204, 226, Phe 166, BAd-α-Glc 312, Tyrβ-NA 307 and TyrPhe 329, 
Fragmentor: 40-80 Volt, Drying gas flow: 10l/min, Nebulizer pressure: 30 psig, Drying gas 
temperature: 350°C, Capillary Voltage: 4000, mobile phase for Tyr, Phe, TyrPhe and 
BAd-α-Glc: acetonitrile 5%, double distilled water 95%, ammonium acetate 10 mM and acetic 
acid 50% to pH 3.2 and for Tyrβ-NA: acetonitrile 20%, double distilled water 80%, ammonium 
acetate 10 mM and acetic acid 50% to pH 3.2 
UV-detection was used to analyze the samples of the partition coefficient determination of 
TyrPhe, Tyrβ-NA and BAd-α-Glc (Perkin Elmer Lamda 5 System). The detailed parameters 
are as followed: Wavelength: TyrPhe 275 nm, Tyrβ-NA 279 nm, BAd-α-Glc 216 nm 
 
Protocol of permeation experiments 
In Passive I a passive transport run over 44 hours was carried out, followed by an applied 
voltage of 250 mV across the membrane over three hours and a second passive run 
(Passive II) over 22 hours. All the samples were analyzed with no previous treatment against 
a set of standard solutions by LC/MS. At the beginning of each stage samples were taken of 
the donor chamber and diluted 400 fold before analyzed. Details of the procedure can be 
found elsewhere7. At the end of Passive I and II a voltage drop of 250 mV was applied for 5 
minutes to record the electrical resistance and to check the integrity of the barrier. At the end 
of each experiment the absence of significant pH and osmolarity changes in both chambers 
was verified. The cumulative amount of the substances permeating the membrane was 
determined as a function of time. Permeability coefficients for each permeant were calculated 
during each experimental stage using the equation: 
 
DAc
1
dt
dQ
=P        Equation 1 
 
where dQ/dt is the slope of the cumulative permeating amount versus time curve, A is the 
area of diffusion and cD is the average donor concentration during the phase. The ratio of the 
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permeation coefficients of iontophoretic phase and Passive I results in the enhancement 
factor for the respective substance. 
 
Protocol of TyrPhe permeation experiments with inhibition 
To inhibit cutaneous metabolism of TyrPhe the corresponding experiments were carried out 
at 4°C8. 
 
Skin extraction 
After each permeation experiment, the skin samples were pulverized and extracted in order 
to determine the skin retention of the substances, which were dissolved in the donor solution. 
Details of the procedure can be found elsewhere7. 
 
Partition coefficient 
Partition coefficients were determined at room temperature in n-octanol/aqueous buffer at pH 
3 and 4.5 using shaking flask method9. Equilibrium concentration were determined in the 
aqueous and the organic phase and analyzed with no previous treatment against a set of 
standards by UV/VIS spectrophotometry. 
 
 
Results and Discussion 
 
Tissue retention and its modulation 
 
The retention of the glucose derivative BAd-α-Glc in the epidermis was reported previously to 
be markedly affected by the presence of the amino acids Tyr and Phe during iontophoresis7.  
BAd-α-Glc, an unionized compound, was serving in those experiments as a reporter of 
electroosmotic flow and Tyr and Phe were the product of the metabolism of the model 
dipeptide TyrPhe in epidermal tissue.  Upon production of Tyr and Phe, iontophoresis at pH 
4.5 and pH 3 caused a considerable amount of BAd-α-Glc to be released from the tissue into 
the receiver solution evoking the impression of permeation enhancement taking place.  By 
comparison, when BAd-α-Glc was present alone at the same pH values, iontophoresis 
elicited a flux retardation of this compound indicating electroosmotic flow occurring in the 
cathode-to-anode direction in accordance with the accepted view of positive fixed epidermis 
charges prevailing in this pH range.  The mechanism, by which the metabolic products of 
TyrPhe reduced the amount of BAd-α-Glc retained by the tissue upon iontophoresis has not 
been adequately understood7.   
The a priori addition of Tyr and Phe to the donor solution produced the same effect as the 
metabolism of TyrPhe (Table 1).  For BAd-α-Glc used alone, an enhancement factor <1 (at 
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pH 4.5) or even negative iontophoretic fluxes (at pH 3) were found, while the addition of Tyr 
and Phe yielded enhancement factors of BAd-α-Glc much greater than one.  The negative 
fluxes are an expression of the cathode-to-anode electroosmotic flow dominating over the 
diffusive flux due to concentration difference between donor and receiver compartment.  The 
>1 enhancement factors correlated with the strong reduction of the amount of BAd-α-Glc 
recovered from the tissue at the end of the experiment, that was observed in the presence of 
the amino acids (Table 2).  This further confirms that these amino acids are responsible for 
discharging BAd-α-Glc from the epidermis into the receiver solution during iontophoresis thus 
having a profound effect on its apparent permeation behavior.  It is interesting to notice that, 
at the employed concentrations, the amount of Tyr and Phe recovered from the epidermis is 
comparable between the two situations, i.e., when these were added a priori to the donor 
solution and when they were produced by metabolism of the dipeptide TyrPhe in the tissue7.   
The amino acids had no influence on the passive permeability of BAd-α-Glc.  This is 
concluded by inspecting the permeability coefficients which were adjusted to an electrical 
membrane resistance of 60 kOhm*cm2 in order to be corrected for inherent differences 
between membrane specimens7 (Table 1).  The added amino acids permeated from the 
donor into the receiver solution.  Both, the average amino acid fluxes (Table 1) and the 
amount of amino acids recovered from the tissue (Table 2) were significantly greater than the 
respective values of the blank runs.   
Tyr and Phe exerted separately the same effect in qualitative terms as their mixture used at 
the same concentration (Table 1).  The apparent enhancement factor of BAd-α-Glc in the 
presence of each of the amino acids was >1 and the amount of BAd-α-Glc retained by the 
tissue was reduced compared to BAd-α-Glc used alone.  The magnitude of these effects, 
however, was smaller for the individual amino acids compared to their mixture.  Other than 
that, the amino acids themselves showed separately the same behavior with respect to 
epidermis permeation and accumulation as their mixture.  This demonstrates that Tyr and 
Phe share the property of displacing BAd-α-Glc from the epidermis upon iontophoresis.  No 
difference in their potency in this respect was obvious within experimental error.  The 
experiments with the individual amino acids were carried out at pH 4.5.  It is considered 
unlikely that the reached conclusions will be different at pH 3 where the effects are, if 
anything, stronger as judged by the studies with the Tyr and Phe mixture. 
The Tyr derivative Tyrβ-NA and the dipeptide TyrPhe did not exert the same effect as Tyr 
and Phe in terms of reduction of tissue retention of BAd-α-Glc and iontophoretic 
enhancement at both pH values (Tables 1 and 2).  Tyrβ-NA is enzymatically stable and 
TyrPhe is used at 4°C in order to prevent metabolism7.  Moreover, Tyrβ-NA and TyrPhe did 
not interfere with the action of Tyr and Phe on the iontophoretic behavior of BAd-α-Glc.  This 
property, therefore, seems so far to be unique to these amino acids.  It is not possible based 
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on the present data to ascertain the chemical characteristics that are required for this 
property.  Since Tyr and Phe have very similar lipophilic and ionized groups as Tyrβ-NA and 
TyrPhe, it seems that only the smaller molecular size of the amino acids distinguishes them 
from the other compounds.   
The effect of adding Tyr and Phe to the donor solution on epidermis permeation and 
iontophoresis of Tyrβ-NA and TyrPhe (4°C) is depicted in Tables 3 and 4, respectively.  The 
amino acids had no impact on the electrical resistance-corrected passive permeability 
coefficients or the iontophoretic enhancement of both compounds.  Also, the amino acids 
had no impact on the epidermis retention of the compounds (Tables 5 and 6).  This effect 
was examined at pH 3 because this is where it was expected to be the strongest based on 
the BAd-α-Glc results.  The result was independent of the presence of BAd-α-Glc (shown for 
Tyrβ-NA).  Further, BAd-α-Glc did not influence Tyrβ-NA permeability, enhancement and 
tissue retention at either pH (Table 3).  These results are consistent with the BAd-α-Glc 
results inasmuch as the effect, or lack thereof, of the amino acids on tissue retention 
correlates with their effect on the measured iontophoretic enhancement.   
Notably, in the same experiments which showed no influence of Tyr and Phe on tissue 
retention and iontophoretic enhancement of Tyrβ-NA and TyrPhe, these amino acids did 
have a major impact on the behavior of BAd-α-Glc.  This demonstrates that this effect of Tyr 
and Phe is not universal but depends on the permeant in question.  The three permeants 
differ in that one of them contains a hexose structure and is uncharged while the other two 
are peptides that are positively charged at the used pH values.  Interestingly, BAd-α-Glc, for 
which the effect was observed, exhibited by far the largerst tissue retention of the three 
compounds when no amino acids were present.  The limited sample size does not allow, of 
course, to reach a conclusion as to the structural characteristics that may be relevant for this 
type of interaction with Tyr and Phe. Clearly, a larger study is required for this purpose.  
Nevertheless, these results draw one's attention to the possible role of tissue retention of 
permeants and drugs for iontophoretic transport and its modulation by physiological 
substances. 
 
Permeant lipophilicity and electroosmosis 
 
Representative iontophoretic enhancement factors of the three model permeants Tyrβ-NA, 
TyrPhe and BAd-α-Glc are collected in Table 7 (last column).  BAd-α-Glc values only in the 
absence of extraneous Tyr and Phe are given.  Tyrβ-NA exhibited the strongest 
enhancement, which was greater at pH 4.5 than at pH 3 while for TyrPhe the opposite was 
true.  These data are evaluated taking into account, in addition to the ionic valence, the 
lipophilicity of the permeants and the effect of electroosmotic flow.  The ionic valence within 
the aqueous domain of the epidermis is relevant in this respect because this domain 
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constitutes the effective pathway that is responsible for electric current conduction and hence 
iontophoretic transport.  The ionic valence of the permeants in the aqueous pathway may 
differ from that in the (aqueous) bulk because of the electrical charges being present in the 
epidermis that, on one hand, give rise to the electroosmotic flow but may also create a pH 
shift in the aqueous micro-environment of the epidermis.  Permeant lipophilicity determines 
its comparative partitioning to the non-aqueous (lipid) and aqueous domains of the epidermis 
and thus the relative significance of the respective pathways for permeation.  Since the 
contribution of non-aqueous pathways to current conduction is probably insignificant, the 
ratio of aqueous to non-aqueous epidermis permeability should influence iontophoretic 
enhancement.  Electroosmotic solvent flow, finally, affects the transport across the 
membrane of all permeants to an extent that depends on the molecular size of the permeant.   
The contribution of these factors to iontophoretic enhancement is assessed simultaneously 
for all three permeants at the applied pH values in a quantitative fashion.  For this purpose, 
the following theoretical expression for the enhancement factor derived previously is 
employed13.   
 
 
Equation 2   
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where, adz  is the average net ionic valence of the permeant in aqueous tissue domains, 
RT
FB ψ∆=  with F the Faraday constant, R the gas constant, T the absolute temperature and 
∆ψ the electrical potential difference applied to the membrane, 
adD
hν=Pe  (Peclet number) 
with ν the linear convective velocity of the solvent, h the thickness of the membrane and Dad 
the diffusion coefficient in aqueous domains, and (Pld/Pad)passive is the ratio of the permeability 
coefficients for lipid (Pld) and aqueous membrane domains (Pad) under passive conditions. 
In this equation, membrane alteration at the used potential difference of 250 mV was 
assumed to be negligible, as verified in earlier studies6.  Equation (2) was fitted 
simultaneously to all experimental enhancement factors (except for BAd-α-Glc at pH 3, see 
below) and the numerical values of the parameters Pe and (Pld/Pad)passive were estimated 
using a least squares optimization procedure (MINSQ software, MicroMath, Inc., Salt Lake 
City, UT, USA).  For these calculations, the following assumptions were made: (i) Pe, an 
expression for electroosmotic flow, depends on pH and temperature but not on the permeant 
since the three permeants studied here have approximately the same molecular weight, (ii) 
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the pH difference between epidermis aqueous domain and bulk is between 0.05 and 0.4 
units resulting from a surface charge density of tissue of 0.0035 and 0.035 C/m2, 
respectively13,14,15; accordingly, calculated values of adz  based on the pKa of the compounds 
differed from the average ionic valence in the bulk, bz ; (iii) the relative value of (Pld/Pad)passive 
using, for example, BAd-α-Glc pH 4.5 as a point of reference, can be approximated based on 
the n-octanol/aqueous buffer partition coefficient, Koct/aq (Table 7), and the aqueous 
domain/bulk partition coefficient given by Equation (3). 
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where, pKa is ionization constant of the permeant, pHb is the pH of the bulk solution, pHad 
refers to the aqueous membrane domain and z2 is the smallest of the two ionic valences of 
the permeant. 
Fitting of Eq. (2) to the data was performed successively for adz  and Kad/b values 
corresponding to the two surface charge densities given above.  The best fit was obtained for 
the parameter values reported in Table 7.  The enhancement factors that were calculated 
using the estimated parameters showed an excellent agreement with the experimental ones.  
The best approximation was reached for the high surface charge density at pH 3 and the low 
one at pH 4.5.  These correspond to small to moderate shifts of the ionic valence in the 
tissue domain compared to the bulk.  Pe values were slightly negative at pH 4.5 indicating a 
small cathode-to-anode electroosmotic flow, which implies an isoelectric point of the tissue of 
somewhat above 4.5.  At pH 3, a ten-fold stronger electroosmotic flow was found compared 
to pH 4.5 suggesting a larger positive charge of the tissue.  This is consistent with the 
surface charge densities that gave the best fit.  No clear dependence of Pe on temperature 
was seen.  This calculation of the contribution of electroosmotic flow to the enhancement 
agrees with previous reports on the role of this factor for iontophoresis1,10,11 and provides a 
quantitative basis for its assessment.  (Pld/Pad)passive, although it differed considerably 
between permeants, reached a maximal value of 0.018, indicating that the aqueous pathway 
vastly dominated transepidermal permeation.  Thus, this factor was not found to significantly 
affect iontophoretic enhancement for the studied compounds.  This might be because even 
the most lipophilic of them was not lipophilic enough to exhibit a pronounced lipid pathway 
permeation.   
The presented analysis has yielded remarkably congruent results in that the estimated 
parameter values could be reasonably interpreted and the calculated enhancement factors 
closely matched the experimental data of all simultaneously analyzed compounds.  This 
verifies the validity of the used model based on Eq. (2) and the underlying mechanistic 
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understanding of the iontophoresis process.  It further demonstrates that this approach, 
besides affording a quantitative evaluation of iontophoretic enhancement, may be used as a 
basis for predicting its outcome. 
Passive epidermis permeability of the studied compounds varied considerably following the 
order Tyrβ-NA < BAd-α-Glc < TyrPhe (Tables 1, 3 and 4).  Permeability coefficients did not 
correlate with the lipophilicity of the compounds as expressed by their octanol/aqueous buffer 
partition coefficient.  This is not surprising in light of the finding of the iontophoretic 
enhancement analysis according to which the aqueous pathway dominated passive 
epidermis permeation.  Hence, permeability differences should be attributable to the different 
accessibility of the aqueous domain for the three permeants.  This is subject to charge-
charge interactions, whereas in the present situation size considerations did not play a role 
because the used compounds had all approximately the same molecular weight.  The 
resulting partition coefficient for the aqueous membrane domain may be expressed by Eq. 
(3).  While this equation predicted a lower partitioning of Tyrβ-NA compared to TyrPhe, the 
difference based on the assumed surface charge densities did not account for the full 
magnitude of the effect in terms of permeability.  Also, the prediction of Eq. (3) of a smaller 
partitioning at pH 3 compared to pH 4.5 was merely tentatively relfected in the smaller 
permeability coefficients at the former pH.  BAd-α-Glc expectedly exhibited no pH 
dependence of permeability.  Finally, no correlation between passive permeability and tissue 
retention of the permeants was found.  Thus, the present data did not allow a full quantitative 
understanding of the passive permeability of the employed permeants to be established. 
The negative iontophoretic fluxes and hence negative enhancement factors obtained for 
BAd-α-Glc at pH 3 (Table 7) could be quantitatively analysed only by relaxing the boundary 
condition of sink in the receiver compartment assumed for the derivation of Eq. (2).   The 
resulting enhancement factor for zero ionic valence applying to BAd-α-Glc is given by Eq. (4). 
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where, CD and CR is concentration in the donor and the receiver compartment, respectively.    
Eq. (4) was used to estimate the magnitude of electroosmotic flow expressed by Pe that 
would lead to a flux from the receiver to the donor compartment and thus against the 
prevailing concentration gradient.  Since the molecules leaving the receiver solution probably 
accumulate in the membrane, an estimated permeant concentration in the outer membrane 
layer facing the receiver solution of 20 µg/ml was used as CD. This corresponds to 0.5% of 
the concentration in the donor solution, i.e., reflects an outer layer thickness of 0.5% of the 
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membrane.  With this value and the measured receiver concentration, Pe values ranging 
between –40 and –0.2 and averaging approximately –15 were calculated.  Using the actual 
donor concentration, no reasonable estimates of Pe could be obtained.  The extremely high 
variability of the data and the required assumptions precluded a meaningful quantitative 
interpretation of the negative flux data.  The value of these data lies in the inference that the 
electroosmotic flow can completely abolish flux originating from a considerable concentration 
gradient. 
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Table 1. Permeability coefficient, P, and enhancement factor, E, of BAd-α-Glc, and Flux, J69h, of Tyr and Phe at pH 3.0 and 4.5 with 
Standard Error of the Mean, SEM, (n=3-8) 
P of BAd-α-Glc and SEM x 109 (in cm/s) E of  BAd-α-Glc 
J69h
c of Tyr and Phe and SEM x 106        
(in ug/s/cm2) pH  
  
Donor composition
Passive I Iontophoresis Passive Ib Tyr Phe 
3.0 BAd-α-Glc 1.55 (0.45) 
d 1.71 
(0.89) 
d NM a NM  
3.0 BAd-α-Glc + Tyr + Phe 20.03 (14.15) 
102.4 
(86.85) 
2.78 
(1.25) 
4.76 
(2.01) 
33.55 
(19.87) 
30.00 
(13.05) 
3.0 BAd-α-Glc + Tyrβ-NA 5.56 (5.35) 
d 2.18 
(1.98) 
d NM a NM a 
3.0 BAd-α-Glc + TyrPhe at 4°C 2.16 (0.63) 
d 0.12 
(0.022) 
d 1.21 
(0.21) 
0.92 
(0.13) 
3.0 BAd-α-Glc + Tyrβ-NA + Tyr + Phe  
3.28 
(1.77) 
11.28 
(4.43) 
1.98 
(1.49) 
4.01 
(0.76) 
10.19 
(4.28) 
5.76 
(2.96) 
3.0 BAd-α-Glc + TyrPhe + Tyr + Phe at 4°C 
5.08 
(4.56) 
16.17 
(13.44) 
2.41 
(0.46) 
3.92 
(1.84) 
7.84 
(2.69) 
9.24 
(1.15) 
3.0     Blank NA b 1.02 (0.23) 
0.74 
(0.012) 
4.5 BAd-α-Glc 2.92 (1.46) 
1.39 
(0.56) 
1.08 
(0.30) 
0.78 
(0.18) NM
 a NM a 
4.5 BAd-α-Glc + Tyr + Phe 5.88 (3.40) 
18.49 
(10.25) 
1.81 
(0.47) 
3.08 
(0.40) 
2.96 
(0.95) 
1.78 
(0.11) 
4.5 BAd-α-Glc + Tyr 2.50 (0.91) 
3.12 
(0.92) 
2.50 
(1.11) 
1.75 
(0.49) 
7.59 
(0.33) NM
 a 
4.5 BAd-α-Glc + Phe 1.19 (0.39) 
2.17 
(0.49) 
1.30 
(0.38) 
2.35 
(0.66) NM
 a 2.72 (0.74) 
4.5 BAd-α-Glc + Tyrβ-NA 0.20 (0.089) 
0.13 
(0.023) 
1.59 
(1.56) 
0.89 
(0.35) NM
 a NM a 
4.5 BAd-α-Glc + TyrPhe at 4°C 8.32 (3.81) 6.85 (5.04) 
1.61 
(0.95) 
0.86 
(0.31) 
1.94 
(0.53) 
0.72 
(0.11) 
4.5     Blank NAb 1.91 (0.21) 
0.84 
(0.14) 
a  NM not measured, b  NA not applicable, c Permeability coefficients of Passive I interpolated to a membrane resistance of 60kOhm*cm2 
d Permeability coefficients and enhancement factors with positive and negative values 
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Table 2. Skin extraction of BAd-α-Glc with Standard Error of the Mean, SEM, (n=3-10) 
Amount ug/skin sample (SEM) pH  
  
Donor composition
BAd-α-Glc Tyr Phe
3.0 BAd-α-Glc 22.43 (4.18) NM a NM a 
3.0 BAd-α-Glc + Tyr + Phe 3.30 (0.79) 3.08 (0.49) 2.53 (0.78) 
3.0 BAd-α-Glc + Tyrβ-NA 23.78 (4.82) NM a 
  
 
 
  
NM a 
3.0 BAd-α-Glc + TyrPhe at 4°C 17.90 (3.98) 1.10 (0.32) 0.94 (0.61) 
3.0 BAd-α-Glc + Tyrβ-NA + Tyr + Phe 8.15 (2.79) 3.95 (0.85) 3.15 (0.40) 
3.0 BAd-α-Glc + TyrPhe + Tyr + Phe at 4°C 
24.63 
(4.55) 
3.94 
(1.65) 
2.82 
(1.34) 
3.0 Blank NA b 1.02 (0.50) 
0.90 
(0.40) 
4.5 BAd-α-Glc 24.10 (5.18) NM a NM a 
4.5 BAd-α-Glc + Tyr + Phe 11.20 (3.02) 4.35 (1.56) 4.13 (0.92) 
4.5 BAd-α-Glc + Tyr 13.53 (4.12) 3.85 (0.73) 1.40 (0.38) 
4.5 BAd-α-Glc + Phe 13.38 (3.99) 1.53 (0.52) 3.75 (0.78) 
4.5 BAd-α-Glc + Tyrβ-NA 23.03 (6.48) NM a NM a 
4.5 BAd-α-Glc + TyrPhe at 4°C 22.63 (5.20) 1.93 (0.65) 1.53 (0.38) 
4.5 Blank NA b 1.45 (0.50) 
1.06 
(0.43) 
a NM not measured, b NA not applicable 
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Table 3. Permeability coefficient, P, and enhancement factor, E, of Tyrβ-NA at pH 3.0 and 4.5 
with Standard Error of the Mean, SEM, (n=3-8) 
P of Tyrβ-NA and SEM x 109 (in cm/s) E of Tyrβ-NA 
pH Donor composition 
Passive I Iontophoresis Passive Ia  
3.0 Tyrβ-NA 0.36 (0.058) 1.20 (0.23) 0.41 (0.052) 3.38 (0.73) 
3.0 Tyrβ-NA + BAd-α-Glc 1.32 (0.70) 
7.29 
(4.33) 
0.45 
(0.095) 
4.46 
(0.91) 
3.0 Tyrβ-NA + Tyr + Phe 0.98 (0.87) 
2.65 
(1.88) 
0.60 
(0.37) 
4.72 
(2.27) 
3.0 Tyrβ-NA + BAd-α-Glc + Tyr + Phe 
0.61 
(0.29) 
4.58 
(2.34) 
0.47 
(0.32) 
4.56 
(1.48) 
4.5 Tyrβ-NA 0.96 (0.53) 
4.76 
(2.44) 
1.02 
(0.63) 
5.65 
(0.62) 
4.5 Tyrβ-NA + BAd-α-Glc 0.88 (0.035) 
4.73 
(0.89) 
1.53 
(0.057) 
5.35 
(0.84) 
a Flux of Passive I phase interpolated to a membrane resistance of 60 kOhm*cm2; 
Regression through the points gave a slope of –1.03 and r=0.66 for pH 3.0 and 4.5
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Table 4. Permeability coefficient, P, and enhancement factor, E, of TyrPhe at pH 3.0 and 
4.5 with Standard Error of the Mean, SEM, (n=3-4) 
P of TyrPhe and SEM x 109 (in cm/s) E of TyrPhe 
pH Donor composition 
Passive I Iontophoresis Passive Ia  
3.0 TyrPhe + BAd-α-Glc at 4°C 
14.86 
(13.37) 
22.57 
(20.3) 
10.01 
(8.84) 
1.57 
(0.23) 
3.0 TyrPhe + BAd-α-Glc + Tyr + Phe at 4°C 
26.21 
(25.74) 
51.13 
(50.44) 
11.83 
(10.84) 
1.62 
(0.17) 
4.5 TyrPhe + BAd-α-Glc at 4°C 
46.75 
(43.12) 
74.25 
(68.36) 
11.59 
(9.58) 
1.06 
(0.43) 
a Flux of Passive I phase interpolated to a membrane resistance of 60 kOhm*cm2;  
Regression through the points gave a slope of –1.04 and r=0.67 for pH 3.0 and 4.5
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Table 5. Skin extractions of Tyrβ-NA with Standard Error of the Mean,  
SEM, (n=3-8) 
pH Donor composition Amount ug/skin sample of Tyrβ-NA (SEM) 
3.0 Tyrβ-NA 12.38 (2.41) 
3.0 12.90 (2.32) 
3.0 Tyrβ-NA +Tyr + Phe 10.43 (3.82) 
3.0 Tyrβ-NA + BAd-α-Glc +Tyr + Phe 12.65 (4.45) 
4.5 Tyrβ-NA 17.45 (3.85) 
4.5 Tyrβ-NA + BAd-α-Glc 16.85 (2.60) 
Tyrβ-NA + BAd-α-Glc 
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Table 6. Skin extractions of TyrPhe with Standard Error of the Mean,  
SEM, (n=4-11) 
pH Donor composition Amount ug/skin sample of TyrPhe (SEM) 
3.0 TyrPhe + BAd-α-Glc at 4°C 9.40 (1.08) 
3.0 TyrPhe + BAd-α-Glc + Tyr + Phe at 4°C 
9.03 
(2.47) 
4.5 TyrPhe + BAd-α-Glc at 4°C 2.80 (0.18) 
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Table 7. Parameters calculated using the model 
pH Temperature(in °C)  bz  adz  Koct/ad 
(Pld/Pad)passive 
x 104 Pe  EEcalculated experim 
3.0 37 Tyrβ-NA 0.98       0.96 4.81 175.6 -4.83 4.15 4.15
 37/4 BAd-α-Glc 0.00     
          
       
         
        
       
0.00 0.13 2.4 a a a 
4 TyrPhe 0.76 0.56 0.80 22.2 -4.83 1.6 1.60
4.5 37 Tyrβ-NA 0.66 0.63 7.28 146.0 -0.36 5.48 5.50
37 BAd-α-Glc 0.00 0.00 0.11 2.0 -0.36 0.83 0.78
4 TyrPhe 0.091 0.082 0.61 11.3 -0.58 1.15 1.06
 4 BAd-α-Glc 0.00 0.00 0.11 2.0 -0.58 0.74 0.86
a Experimental enhancement factors partly negative for separate evaluation see text
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E  Appendix 
 
This chapter contains the additional procedures and validation experiments, which are not 
yet described in the original papers of the previous section. 
 
Choice of pH-values and buffer system 
 
It was decided to carry out the permeation experiments at pH 3, where the skin is suspected 
to carry a net positive charge indicating an electroosmotic flow from cathode to anode and at 
pH 4.5, which lies in the region of the isoelectric point of the skin and consequently no 
electroosmotic flow occurs (Hoogestraate et al. 1994, Luzardo-Alverez et al. 1998, Marro et 
al. 2001). 
 
On the basis of these considerations it was decided to use Teorell-Stenhagen buffer system 
for both pHs (Wissenschaftliche Tabellen Geigy 1979). 
 
Composition of buffer solutions 
 
Universal buffer  Citric acid monohydrate      30.5 mM 
    Boric acid        57.3 mM 
    Phosphoric acid 85%           50.0 mM 
    1M NaOH           343 ml 
    Double distilled water          657 ml 
 
Buffer pH 3    Teorell-Stenhagen Universal buffer        200 ml 
    1M HCl             57 ml 
    Double distilled water          743 ml 
 
Buffer pH 4.5   Teorell-Stenhagen Universal buffer        200 ml 
    1M HCl             48 ml 
Double distilled water          752 ml 
 
For the donor solutions the substances were dissolved in one of the buffer. Then the buffer 
solution and the donor solution were isotonized by an extra of an adequate amount of 
sodium chloride. 
 
 
E.1 Assay of TyrPhe, Tyrβ-NA, BAd-α-Glc, Tyr, Phe and Benzyl alcohol 
 
Solubility and partition coefficient 
 
UV-detection was used to analyze TyrPhe, Tyrβ-NA and BAd-α-Glc. Therefore a Perkin 
Elmer Lamda 5 System was used. 
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The detailed parameters are as follows: 
 
Wavelength: 
 
TyrPhe  275 nm 
Tyrβ-NA  279 nm 
BAd-α-Glc  216 nm 
 
Permeation and stability experiments 
 
MS combined with HPLC was used to analyze TyrPhe, Tyrβ-NA, BAd-α-Glc, Tyr and Phe. 
Agilent 1100 and HP 1100 system combined with an autosampler and an UV detector was 
used to analyze the compounds. 
The detailed parameters are as follows: 
 
HPLC 
 
Column:    CC 125/2 Spherisorb 80-5 ODS-2 
Flow Rate:    0.25 ml/min 
Pressure:    approx. 90 bar 
Retention time (minutes):  
TyrPhe   10-11 
 
Tyr    2.0–3.0 
 
Phe    2.5–3.5 
 
BAd-α-Glc:  
- alone    12-13 
- plus TyrPhe   12-13  
- plus Tyr and/or Phe  12-13 
- plus Tyrβ-NA   2.5-3.5 
  
Tyrβ-NA   12-13 
 
Wavelength:   
TyrPhe     214 nm 
BAd-α-Glc     214 nm 
Tyr      214 nm 
Phe     214 nm 
Tyrβ-NA    245 nm 
  
Injection volume:   100 µl 
Solvent system:   
TyrPhe, BAd-α-Glc,   Acetonitrile 5% 
Tyr and Phe   Double distilled water 95%,  
Ammonium acetate 10 mM  
Acetic acid 50% to pH 3.2 
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Tyrβ-NA   Acetonitrile 20%  
Double distilled water 80%  
Ammonium acetate 10 mM 
Acetic acid 50 % to pH 3.2 
 
MS 
 
Mode:     SIM 
Polarity:    Positive 
Ionization mode:   API-ES  
Peak width:    0.2 min 
Cycle time:    1.2 s/cycle 
Time filter:    on 
 
Mass range: 
TyrPhe   329 
Tyr    182, 204, 226 
Phe    166 
BAd-α-Glc:   312 
Tyrβ-NA   307 
Fragmentor (V): 
TyrPhe   80 
Tyr    40 
Phe    40 
BAd-α-Glc:   40 
Tyrβ-NA   70 
Gain:     1 
SIM resolution:   low 
 
Drying gas flow:   10 l/min 
Nebulizer pressure:   30 psig 
Drying gas temperature:  350°C 
Capillary Voltage (V):   4000 
 
Enzymatic stability of BAd-α-Glc 
 
HPLC was used to analyze benzyl alcohol. Agilent 1100 and HP 1100 system combined with 
an autosampler and a UV detector was used to analyze the compounds. 
The detailed parameters are as follows: 
 
Column:    CC 125/2 Lichrospher 100-5 RP-18ec 
Flow Rate:    0.25 ml/min  
Pressure:    approx. 80 
Retention time (minutes):  6-7 
Wavelength:    258 nm 
Injection volume:   100 µl 
Solvent system:   Acetonitrile 15% 
Double distilled water 85% 
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E.2 Physico-chemical characterization of TyrPhe, Tyrβ-NA and BAd-α-Glc 
E.2.1 Ionization constants 
 
Ionization constants are used to measure the strength of acids and bases. They reveal the 
proportion of the different ionic species of a compound at any pH. 
HA is ionized as follows: 
 
 Ka 
HA               H+  +  A- 
 
The ionization constant is defined as 
 
[ ][
[ ]
]
HA
A H
K
-
a
+
=  
 
and as inversed log 
 
 [HA] pKa = pH + log 
[A-]  
 
pKa is defined as pH where [HA] and [A-] are equal (point of half-neutralization) and thus the 
log of their ratio is zero. 
 
Experimental procedures 
 
TyrPhe (1.2 mM) and Tyrβ-NA (0.11 mM) were dissolved separately in double distilled water 
with an equivalent of HCl. The solutions were then titrated with 10 mM NaOH and 1 mM 
NaOH, respectively. The titrations with Tyrβ-NA had to be gassed with argon because of 
greater variations of pH values. 
The point of half-neutralization was determined by the tangent procedure (Hartke and 
Mutschler 1989). 
 
Results 
 
Table 1. Determination of pKa for TyrPhe and Tyrβ-NA with Standard Error of the Mean, 
SEM, (n=4) 
 pKa SEM 
TyrPhe 3.50 0.00 
Tyrβ-NA 4.78 0.03 
Tyr* 2.20, 9.11, 10.13 - 
Phe* 2.16, 9.18 - 
*The pKa values for Try and Phe were taken from literature (Vollhardt 1990) 
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E.2.2 Solubility of TyrPhe and Tyrβ-NA 
 
To decide the donor concentration, the saturation concentration was determined. 
 
Experimental procedures 
 
The component was added in surplus to Teorell-Stenhagen buffer pH 3 and pH 4.5. The 
suspensions were shaken by magnetic stirrer and heated up to 37°C by water bath. Each 24 
hours samples were withdrawn und the amount determined by UV-detection as described 
above. This process was repeated until the concentration measured did not rise on 
successive measurements. 
 
Results 
 
Table 2. Solubility of TyrPhe and Tyrβ-NA 
 Solubility mg/ml 
 pH 3 pH 4.5 
TyrPhe 1.4 0.8 
Tyrβ-NA 1.1 0.6 
 
The aqueous solubility of BAd-α-Glc is 50 mg/ml (Certificate of Analysis, Aldrich, 
Switzerland). 
 
E.2.3 Stability 
 
The stability of TyrPhe and BAd-α-Glc should be ensured during storage and throughout the 
experiment. Tyrβ-NA was assumed to be stable due to the side-chain protecting group at the 
C-terminus. 
 
E.2.3.1 Chemical stability 
 
The chemical stability was determined for TyrPhe and BAd-α-Glc dissolved in buffer at pH 3 
and 4.5. 
 
Experimental procedures 
 
At pH 3 and pH 4.5 TyrPhe solutions (3.8 mM) were put in a water bath and shaken 
continuously by magnetic stirrer at 37°C over a period of 95 hours. Every 10-12 hours the pH 
values was monitored and samples were withdrawn and analyzed as described above. 
The same procedure was carried out with BAd-α-Glc solutions (1.5 mM). 
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Results 
 
The pH of all solutions remained constant during the period of the experiment (maximum 
variations were ±0.2 pH units). 
TyrPhe and BAd-α-Glc concentration remained stable (see Figure 1) and no degradation 
products were measured after 95 hours. 
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Figure 1. Chemical stability of TyrPhe and BAd-α-Glc over 95 hours 
 
E.2.3.2 Enzymatic stability of TyrPhe 
 
The stability was determined by measuring the decrease of TyrPhe concentration and the 
increase of the generated degradation products Tyr and Phe. 
The experimental procedure was carried out using reflection method (Boderke et al. 1998). 
Therefore, the heat-separated epidermis was interposed between two half-cells, the viable 
epidermis facing the donor chamber. Between the receiver chamber and the stratum 
corneum, a plastic foil was mounted as an impermeable barrier (see Figure 2). 
 
 
 
 
Figure 2. Reflection set-up consisting of donor compartment (left), heat-separated epidermis 
(middle) and impermeable barrier (right; plastic foil). S, substrate; M, metabolite 
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Experimental procedures 
 
After the membrane was clamped between donor compartment, plastic foil and receiver 
compartment, 7.5 ml of TyrPhe solution (1.2 mM) at pH 3 or pH 4.5 was filled in the donor 
compartment. Analogue to permeation experiments the cells were stirred at 400 rpm with 
teflon paddles in a water bath at 37°C over a period of 70 hours. Every 10-15 hours samples 
were withdrawn and analyzed as described above. 
 
Results 
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Figure 3. Reflection boundary set-up: Decrease of the TyrPhe concentration in the presence 
of human epidermal membrane 
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Figure 4. Generation of the degradation products Tyr and Phe in the compartment at pH 3 
and 4.5 
 
Reflection experiments showed a decrease of TyrPhe concentration of 12% at pH 3 and 45% 
at pH 4.5 after 70 hours. Both degradation products appeared within the first 20-30 hours at 
pH 3 and the first 5 hours at pH 4.5, respectively (see Figure 3 and 4). 
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As explained in details in the original papers in the previous section, the amount of generated 
Try and Phe accounted exactly for the concentration decrease of TyrPhe. 
 
E.2.3.3 Enzymatic stability of BAd-α-Glc 
 
Instead of analyzing the decrease of BAd-α-Glc concentration it was decided to determine 
the stability of BAd-α-Glc by measuring the degradation product benzyl alcohol. 
 
Experimental procedures 
 
1 ml of BAd-α-Glc solution (1.5 mM) at pH 3 or pH 4.5 was added to a piece of heat-
separated epidermis of the same size like those of the permeations experiments. During 
70 hours samples of 100 µl were withdrawn every 8-17 hours and analyzed as described 
above. 
 
Results 
 
The degradation product was measured in a concentration less than 0.5% at pH 3 and 
pH 4.5 indicating no enzymatic degradation of BAd-α-Glc. 
 
E.2.3.4 Stability during voltage application of 250 mV 
 
The stability of the dipeptide TyrPhe during voltage application of 250 mV was investigated. 
 
Experimental procedures 
 
Instead of human epidermal membrane, 75 membrane filters (Isopore Membrane Filter, 
Filter Type 0.1 µm VCTP, Milipore AG) with a pore size of 0.1 µm were used. Each half-cell 
was filled with TyrPhe solution at pH 4.5, which was analogue to the permeation experiment. 
During 8 hours a voltage of 250 mV was applied and each hour a sample was withdrawn. 
 
Results 
No decrease of TyrPhe concentration (see Figure 5) and no generation of any degradation 
products (Tyr or Phe) were recognized. Therefore, TyrPhe was regarded as stable during a 
voltage application of 250 mV over 8 hours. 
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Figure 5. Stability of TyrPhe during voltage application of 250 mV over 8 hours 
 
E.2.4 Partition coefficient 
 
Partition coefficient is a measure of partitioning of non-ionized substances between two 
immiscible phases. For most purposes these phases are an organic solvent and water. The 
partition coefficient K of a substance is defined as the ratio of the concentration in the two 
phases at equilibrium. 
 
w
o
C
C
=K  
 
where Co is the concentration in the organic and Cw the concentration in the aqueous phase. 
Sometimes the partition coefficient is determined under conditions where the substance is 
partially ionized. In this case the ratio of the concentrations is termed apparent partition 
coefficient to distinguish from the real partition coefficient for the totally non-ionized 
compound. 
 
The real partition coefficient was measured for BAd-α-Glc and the apparent partition 
coefficient was measured for TyrPhe and Tyrβ-NA at pH 3 and 4.5, using n-octanol and 
Teorell-Stenhagen buffer as organic and aqueous phase. n-octanol has been widely used as 
model for biological membranes (Lund 1994). Its long non-polar carbon atom chain 
represents the bound or free fatty acid chains and the polar heads of a membrane. 
It is expected that the apparent partition coefficient of Tyrβ-NA at pH 3 is smaller than at pH 
4.5 because of the lack of the carboxyl group. This leads to a greater amount of ionized 
molecules at pH 3. In contrast, TyrPhe carries more charge at pH 4.5 (amino group and 
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carboxyl group) and should therefore have a higher partition coefficient at pH 3. With the 
uncharged BAd-α-Glc the partition coefficient should be the same for both pHs. 
The real and the apparent partition coefficient were measured using flask shaking method. 
Therefore the two immiscible solutes were shaken and analyzed for content (Leo et al. 
1971). 
 
Experimental procedures 
 
Each substance was dissolved in the medium (n-octanol or buffer) in which it was less 
soluble by stirring it continuously over 48 hours followed by ultrasonic for 15 minutes. The 
overstanding solution was centrifuged and 20 ml were added to an equal volume of buffer 
(pH 3 or pH 4.5) or n-octanol. This mixture was shaken 20 times during one minute by 
inverting the flask at 180°. This procedure was carried out every 10 minutes during the first 
hour. Then it was shaken 20 times in a minute once in an hour for the following 5 hours. The 
mixture was allowed to stand 10 minutes before the two phases were separated, centrifuged 
at 4000 rpm for 15 minutes and analyzed by UV-detection as described above. 
 
Results 
 
Table 3. Determination of partition coefficients of TyrPhe, Tyrβ-NA and BAd-α-Glc at pH 3 
and 4.5 with Standard Error of the Mean, SEM, (n=4-8) 
  Partition coefficient K  
(SEM) 
pH 3 BAd-α-Glc  0.11  (0.071) 
 TP 0.80  (0.170) 
 Tyrβ-NA 4.81  (0.086) 
pH 4.5 BAd-α-Glc 0.13  (0.062) 
 TP 0.61  (0.074) 
 Tyrβ-NA 7.28  (0.160) 
 
 
E.3 Validation for transport studies 
 
The diffusion cells used in this project were already used in our laboratory. They have been 
described and validated in detail in earlier PhD thesis’s (Lütolf 1997 and Kochhar 2001). 
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E.4 Experimental determinations 
E.4.1 Determination of the transport area 
 
The transport area of both half-cells is relevant for the calculation of the flux of the 
permeants. Therefore, the inner diameter was measured at 3 different positions by a Vernier 
Capiller. 
 
Table 4. Transport area of the half-cells 
Transport cell Mean inner diameter (d) 
(cm) 
Transport area (cm2) 
2
2
d 

π=  
 Donor Receiver Mean  
Cell a 1.617 1.600 1.608 2.03 
Cell b 1.600 1.600 1.600 2.01 
Cell c 1.600 1.600 1.600 2.01 
Cell d 1.617 1.563 1.590 1.99 
Cell e 1.620 1.622 1.621 2.06 
Cell f 1.600 1.625 1.613 2.04 
Cell h 1.600 1.500 1.550 1.89 
Cell I 1.600 1.625 1.613 2.04 
Cell k 1.654 1.649 1.615 2.14 
Cell y 1.625 1.600 1.613 2.04 
 
 
E.4.2 Determination of the thickness of heat-separated epidermal membrane 
 
The thickness of the epidermis was measured by micrometer direct after the heat separation.  
 
Experimental procedures 
 
After the heat separation, the skin specimens were lying on a piece of aluminium foil. These 
two layers were mounted between two cover-glasses (18x18 mm, thickness 0.28 mm) and 
measured by micrometer on 3 different positions in triplicate in order to investigate 
reproducibility. The thickness of the two cover-glasses and the aluminium foil was measured 
and subtracted from the mean thickness of the whole before measured system (Lütolf 1997).  
 
Results 
 
This method showed reproducibility and a mean thickness of 43 µm ± 5 µm (n=16). 
 
 
 84
Appendix 
_________________________________________________________________________________ 
E.4.3 Osmolarity and pH during permeation experiment 
 
As a control the osmolarity and the pH of donor and receiver solutions was measured before 
and after each permeation experiment by an osmo- and a pH-meter. If the difference of the 
values before and after the permeations experiment was greater than 15 mosmol and 0.2 pH 
units the transport data of that cell was not included in the results. 
 
E.4.4 Pulverization of skin 
E.4.4.1 Determination of the membrane extraction 
 
After each permeation experiment, the skin sample was pulverized in order to determine the 
amount of the substances, which were dissolved in the donor solution and their possible 
degradation products. 
Experimental procedures and results are described in chapter C ‘Publications’. 
 
E.4.4.2 Recovery from epidermal membrane 
 
This procedure was performed to estimate the accuracy of the substance extraction of the 
skin pulverization experiments. 
 
Experimental procedures 
 
BAd-α-Glc solution was applied on epidermal membrane and paper filter as a control. After 
drying, the samples were pulverized and diluted in HPLC eluant and then extracted as 
described above. The ratio of the determined BAd-α-Glc concentration in the epidermal 
membrane to the BAd-α-Glc concentration in the paper filter gave the recovery of 59%. 
 
E.4.5 Time dependent resistance changes of the membrane 
 
Experimental procedure 
 
The assessment of this experiment corresponded to the permeation experiments. Buffer 
solution pH 3 (cell 1 and cell 2) or pH 4.5 (cell 3) was filled in both compartments. Every 
10-15 hours a voltage of 250 mV was applied during 10 minutes. The current flow of each 
skin specimen was measured and recorded and though the corresponding resistance 
calculated. 
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Results 
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Figure 6. Resistance changes of three membrane specimens over 70 hours 
 
The resistances of the membranes remained constant over 70 hours at both pHs. 
 
E.4.6 Procedure of the permeation experiments 
 
Setting the cells 
 
Full thickness skin was heat separated at 60°C as described by Sims et al. 1991. The 
epidermal membrane was cut into pieces using a circular punch with a diameter of 2.5 cm. 
The skin piece was put in buffer with the stratum corneum facing the upper side. The 
receiver half-cell was immersed into the buffer and lifted out the membrane with the stratum 
corneum on its exposed side. The receiver half-cell with the membrane was covered 
carefully by the donor half-cell. The two half cells were pressed one on the other and sealed 
with teflon tape. The whole cell was then secured further with teflon covers from donor and 
receiver side, which were screwed together to fix the cell tightly. The donor cell was filled 
with approximately 3 ml of buffer solution and held in upright position for 15 minutes to check 
any leaking. 
Meanwhile, buffer was degassed in the ultrasonic bath and filled in the Luggin capillaries 
without any bubbles. The capillaries were carefully fitted in the leak proved and dried cells 
and secured with teflon clamps.  
The cell was then screwed to a teflon board, which rested in a water bath at 37°C and could 
hold five of such cells. Reference and working electrodes as well as stirrers were fitted in the 
cell. The stirrers were connected with a beaded chain, which was connected to a motor 
operated at 400 rpm. The donor and receiver half-cells were filled with 7.5 ml of donor or 
buffer solution, respectively. Samples of 50 µl in the donor and 200 µl in the receiver 
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compartment were withdrawn. The volume drawn from the receiver compartment was 
replenished with buffer solution only. Samples were withdrawn regularly at determined 
intervals and analyzed against a set of standard solutions. The cumulative amount was 
calculated as shown in the next section. 
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E.4.7 Cumulative amount permeation 
 
As an example an experiment with TyrPhe, BAd-α-Glc, Tyr and Phe dissolved in the donor 
solution is shown. 
 
C1: concentration calculated from the calibration curve 
C2: concentration in the receiver compartment at time x (in 7.5 ml) 
C3: concentration drawn from the cell at time x (in 0.2 ml) 
C4: corrected cumulative amount at time x 
 
Calibration curve used for TyrPhe: y = 1909247x + 137101 
     r2 = 1.00 
 
 
Table 5. The cumulative amount of TyrPhe over 69 hours 
Stage Time Area  
C1 
(µg/ml) 
C2 
(µg/7.5ml) 
C3 
(µg/0.2ml) 
C4 
(in µg) 
 0.00      
 1.50 290718 0.100 0.752 0.020 0.752 
 3.00 334143 0.115 0.864 0.023 0.884 
 16.50 3584440 1.236 9.267 0.247 9.310 
 18.00 3597650 1.240 9.301 0.248 9.591 
 19.50 3579150 1.234 9.253 0.247 9.791 
Stage I 21.00 3597170 1.240 9.300 0.248 10.085 
 22.50 3576030 1.233 9.245 0.247 10.278 
 24.00 3625980 1.250 9.374 0.250 10.654 
 25.50 3649710 1.258 9.436 0.252 10.965 
 26.50 3656810 1.261 9.454 0.252 11.235 
 41.50 4277500 1.474 11.059 0.295 13.092 
 42.00 4289880 1.479 11.091 0.296 13.419 
 43.50 4294530 1.480 11.103 0.296 13.727 
 44.00 4239520 1.461 10.961 0.292 13.880 
 44.67 4166490 1.436 10.772 0.287 13.984 
 45.00 4188780 1.444 10.829 0.289 14.329 
Stage II 45.33 4045650 1.395 10.459 0.279 14.248 
(250 mV) 45.67 4064940 1.401 10.509 0.280 14.576 
 46.33 4021330 1.386 10.396 0.277 14.744 
 46.67 4054170 1.398 10.481 0.280 15.106 
 47.00 3896490 1.343 10.074 0.269 14.978 
 48.50 3706040 1.278 9.581 0.256 14.754 
 50.00 3773690 1.301 9.756 0.260 15.184 
Stage III 65.50 3998770 1.378 10.338 0.276 16.027 
 66.00 3938130 1.358 10.181 0.272 16.145 
 67.50 4068260 1.402 10.518 0.280 16.753 
 69.00 4029250 1.389 10.417 0.278 16.933 
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Figure 7. Permeation profile of TyrPhe 
 
 
Table 6. Calculation of the permeability coefficient P and enhancement factor E of TyrPhe  
Stage Slope         (in µg/h) 
Donor conc. 
(in µg/ml) 
Permeability 
coefficient P 
Enhancement 
factor E 
Stage I 7.97E-5 579 6.67E-8  
Stage II   (250 mV) 1.16E-4 556 1.01E-7 1.52 
Stage III 2.45E-5 540 2.20E-8  
Area of the cell used: 2.064 cm2 
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Calibration curve used for BAd-α-Glc: y = 1966630x + 147091 
      r2 = 1.00 
 
 
Table 7. The cumulative amount of BAd-α-Glc over 69 hours 
Stage Time Area 
C1 
(µg/ml) 
C2 
(µg/7.5ml) 
C3 
(µg/0.2ml) 
C4 
(in µg) 
 0.00      
 1.50 157528 0.005 0.040 0.001 0.040 
 3.00 178874 0.016 0.121 0.003 0.122 
 16.50 1583460 0.730 5.478 0.146 5.482 
 18.00 1538750 0.708 5.307 0.142 5.458 
 19.50 1594910 0.736 5.521 0.147 5.813 
Stage I 21.00 1562840 0.720 5.399 0.144 5.838 
 22.50 1609770 0.744 5.578 0.149 6.161 
 24.00 1642560 0.760 5.703 0.152 6.435 
 25.50 1618520 0.748 5.611 0.150 6.495 
 26.50 1668900 0.774 5.804 0.155 6.837 
 41.50 1626460 0.752 5.642 0.150 6.830 
 42.00 1695530 0.787 5.905 0.157 7.244 
 43.50 1698710 0.789 5.917 0.158 7.414 
 44.00 1678650 0.779 5.841 0.156 7.495 
 44.67 1718770 0.799 5.994 0.160 7.804 
 45.00 1680110 0.780 5.846 0.156 7.816 
Stage II 45.33 1657340 0.768 5.760 0.154 7.885 
(250 mV) 45.67 1724730 0.802 6.017 0.160 8.296 
 46.33 1763570 0.822 6.165 0.164 8.604 
 46.67 1736650 0.808 6.062 0.162 8.666 
 47.00 1711770 0.796 5.967 0.159 8.733 
 48.50 1685280 0.782 5.866 0.156 8.791 
 50.00 1734260 0.807 6.053 0.161 9.134 
Stage III 64.50 1817060 0.849 6.369 0.170 9.611 
 66.00 1828050 0.855 6.411 0.171 9.823 
 67.50 1801470 0.841 6.309 0.168 9.893 
 69.00 1818070 0.850 6.372 0.170 10.124 
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Figure 8. Permeation profile of BAd-α-Glc 
 
 
Table 8. Calculation of the permeability coefficient P and enhancement factor E of BAd-α-Glc 
Stage Slope (in µg/h) 
Donor conc. 
(in µg/ml) 
Permeability 
coefficient P 
Enhancement 
factor E 
Stage I 4.40E-5 3505 6.08E-9  
Stage II  (250 mV) 1.24E-4 3403  1.77E-8 2.91 
Stage III 1.46E-5 3332 2.12E-9  
Area of the cell used: 2.064 cm2 
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Calibration curve used for Tyr: y = 21396x + 1597.8 
     r2 = 0.999 
 
 
Table 9. The cumulative amount of Tyr over 69 hours 
Stage Time Area 
C1 
(µg/ml) 
C2 
(µg/7.5ml) 
C3 
(µg/0.2ml) 
C4 
(in µg) 
 0.00      
 1.50      
 3.00      
 16.50 10656.2 0.423 3.175 0.085 3.175 
 18.00 10663.9 0.424 3.178 0.085 3.263 
 19.50 10742.7 0.427 3.206 0.085 3.375 
Stage I 21.00 10908.7 0.435 3.264 0.087 3.519 
 22.50 11478.7 0.462 3.464 0.092 3.806 
 24.00 11778.9 0.476 3.569 0.095 4.003 
 25.50 11975.2 0.485 3.638 0.097 4.167 
 27.00 12068.6 0.489 3.670 0.098 4.297 
 40.50 13824.6 0.571 4.286 0.114 5.010 
 42.00 14112.4 0.585 4.387 0.117 5.225 
 43.50 14299.4 0.594 4.452 0.119 5.408 
 44.00 15453.1 0.648 4.857 0.130 5.931 
 44.67 14826 0.618 4.637 0.124 5.841 
 45.00 14727.2 0.614 4.602 0.123 5.930 
Stage II 45.33 14300.8 0.594 4.453 0.119 5.903 
(250 mV) 45.67 14263 0.592 4.440 0.118 6.009 
 46.33 13869.7 0.574 4.302 0.115 5.989 
 46.67 13616.9 0.562 4.213 0.112 6.015 
 47.00 13485.1 0.556 4.167 0.111 6.081 
 48.50 11517.1 0.464 3.477 0.093 5.503 
 50.00 11803.6 0.477 3.577 0.095 5.696 
Stage III 64.50 14202 0.589 4.418 0.118 6.632 
 66.00 14374.2 0.597 4.479 0.119 6.810 
 67.50 14095.9 0.584 4.381 0.117 6.832 
 69.00 14724.1 0.613 4.601 0.123 7.169 
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Figure 9. Permeation profile of Tyr 
 
 
 
Table 10. Calculation of the permeability coefficient P and enhancement factor E of Tyr 
Stage Slope        (in µg/h) 
Donor conc. 
(in µg/ml) 
Permeability 
coefficient P 
Enhancement 
factor E 
Stage I 7.97E-5 579 6.97E-8  
Stage II  (250 mV) 1.16E-4 556 1.18E-7 1.22 
Stage III 2.45E-5 540 739E-8  
Area of the cell used: 2.064 cm2 
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Calibration curve used for Phe: y = 1465831x + 237088 
     r2 = 0.999 
 
Table 11. The cumulative amount of Phe over 69 hours 
Stage Time Area 
C1 
(µg/ml) 
C2 
(µg/7.5ml) 
C3 
(µg/0.2ml) 
C4 
(in µg) 
 0.00      
 1.50 192295 0.062 0.466 0.012 0.466 
 3.00 220206 0.071 0.533 0.014 0.546 
 16.50 1748900 0.565 4.236 0.113 4.263 
 18.00 1723830 0.557 4.175 0.111 4.315 
 19.50 1680400 0.543 4.070 0.109 4.321 
Stage I 21.00 1651760 0.533 4.001 0.107 4.360 
 22.50 1578860 0.510 3.824 0.102 4.291 
 24.00 1480820 0.478 3.587 0.096 4.155 
 25.50 1457440 0.471 3.530 0.094 4.194 
 26.50 1434550 0.463 3.475 0.093 4.233 
 41.50 1523080 0.492 3.689 0.098 4.540 
 42.00 1449060 0.468 3.510 0.094 4.459 
 43.50 1494390 0.483 3.620 0.097 4.662 
 44.00 1458600 0.471 3.533 0.094 4.672 
 44.67 1401290 0.453 3.394 0.091 4.628 
 45.00 1465690 0.473 3.550 0.095 4.874 
Stage II 45.33 1420650 0.459 3.441 0.092 4.860 
(250 mV) 45.67 1395730 0.451 3.381 0.090 4.891 
 46.33 1434570 0.463 3.475 0.093 5.075 
 46.67 1382900 0.447 3.350 0.089 5.043 
 47.00 1303500 0.421 3.157 0.084 4.940 
 48.50 1201090 0.388 2.909 0.078 4.776 
 50.00 1226260 0.396 2.970 0.079 4.914 
Stage III 64.50 1709790 0.552 4.141 0.110 6.165 
 66.00 1758250 0.568 4.259 0.114 6.393 
 67.50 1647800 0.532 3.991 0.106 6.239 
 69.00 1637770 0.529 3.967 0.106 6.321 
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Figure 10. Permeation profile of Phe 
 
 
Table 12. Calculation of the permeability coefficient P and enhancement factor E of Phe  
Stage Slope        (in µg/h) 
Donor conc. 
(in µg/ml) 
Permeability 
coefficient P 
Enhancement 
factor E 
Stage I 2.35E-5 500 4.53E-8  
Stage II   (250 mV) 3.62E-5 483 7.21E-7 1.59 
Stage III 2.21E-5 472 4.52E-8  
Area of the cell used: 2.064 cm2 
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Figure 11. Electrical profile during stage II (250 mV) 
 
Table 13. Electrical data 
Stage Resistance (in kΩ*cm2) Current (in µA) 
Stage I 19.81 25.9 
Stage II (250 mV) 19.88 25.8 
Stage III 18.10 28.3 
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E.5 List of instruments 
 
Balance, Mettler AT 261DeltaRange®,No. P27846, Mettler Toledo AG, Greifensee ZH, 
Switzerland 
 
Centrifuge, Centrifuge Sigma 302K, No. 22644, Sigma, Osterode/Harz, Germany 
 
Destillationsapparatur, Büchi Laboratoriums-Technik AG, Flawil/SG, Switzerland 
 
Freeze mill, 6750, No. 98060, SPEX CertiPrep, Incorporated, New Jersey, USA 
 
HPLC-MS, Hewlett Packard HPLC/MS-System, Serie 1100, Hewlett Packard, Switzerland 
 Isocratic pump:  Type G1310A  
    Serie No. DE52700102 
 Vacuum degasser: Type G1322A 
    Serie No. JP52900335 
 Autosampler:  Type G1329A 
    Serie No. DE23909716 
 UV-Detector:  Type G1314A 
    Serie No. JP55100233 
 Massdetector:  Type G1946C 
    Serie No. US11811027 
Software:  LC/MSD ChemStation 
    Rev. A.09.01 [1206] 
 HPLC Column: CC 125/2 SPHERISORB 80-5 ODS-2 
    Kat No. 728007.02 
    Serie No. 9081978, Batch 123 
    Macherey-Nagel, Schweiz 
 
Glas cells and capillaries (Iontophoresis), Glastechnik Rahm, 4132 Muttenz, Switzerland 
 
Micrometer, Isomaster® (0-25 mm, 0.01 mm), No. 028374, Tesa SA, Renens VD, 
Switzerland 
 
Osmometer, Roebling Osmometer Type 4B, No. 8606007, Auer Bittmann Soulié AG, 
Dietikon ZH, Switzerland 
 
Perkin Elmer Spectrometer Lambda 20, No. 20029, Perkin Elmer, Überlingen, Germany 
 
pH-meter, Metrohm 744 pH meter, Type 1.744.0010, No. 12190, Metrohm, Herisau, 
Switzerland 
 
Potentiostat, Potentiostat für Gleichstrom, Institut für Physik der Universität Basel, 
Switzerland 
 
Potentiostat writer, model DCR 520C, Instruments AG, Münchenstein, Switzerland 
 
Reference electrodes, Metrohm Ag,Ag/Cl-Elektroden/0…80°C, Type 6.0724.140, Metrohm, 
Herisau, Switzerland 
 
Stirring system (Iontophoresis), RE 162 IKA Motor, No. 725921, Janke & Kunkel, IKA-
Labortechnik, Staufen i.Br., Deutschland 
 
Synthetic membranes, IsoporeTM Membrane Filters, Filter type 0.1 µm VCTP, No. 
VCTP02500, Lot No. R3CN98135, Millipore AG, Volketswil ZH, Switzerland 
Vernier Calliper, Etalon 75-115821 T, Pierre Roch, Rolle GmbC, Switzerland 
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Waterbath (Iontophorese), Julabo 36B, Type VC/3, No. 1099332668 Julabo Labortechnik 
GmbH, Seelbach, Germany 
 
Waterbath, Variomag® Electronicrührer, Type E, No. 00202320951, Julabo Labortechnik 
GmbH, Munich, Germany 
 
Ultrasonic bath, Retsch Type URG, No. 306059007, Retsch GmbH&Co., Haan, Germany 
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